0001575705-19-000119.txt : 20191114 0001575705-19-000119.hdr.sgml : 20191114 20191114163414 ACCESSION NUMBER: 0001575705-19-000119 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: POWERVERDE, INC. CENTRAL INDEX KEY: 0000933972 STANDARD INDUSTRIAL CLASSIFICATION: MOTORS & GENERATORS [3621] IRS NUMBER: 880271109 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-27866 FILM NUMBER: 191220957 BUSINESS ADDRESS: STREET 1: 21615 N. 2ND AVENUE CITY: PHOENIX STATE: AZ ZIP: 85027 BUSINESS PHONE: 623-780-3321 MAIL ADDRESS: STREET 1: 21615 N. 2ND AVENUE CITY: PHOENIX STATE: AZ ZIP: 85027 FORMER COMPANY: FORMER CONFORMED NAME: VYREX CORP DATE OF NAME CHANGE: 19951206 10-Q 1 pwvi_3q19.htm FORM10-Q

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 


Form 10-Q


 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Quarterly Period ended September 30, 2019

 

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Commission file number: 000-27866

 


 

POWERVERDE, INC.  

(Exact name of Registrant as specified in its charter)

 


 

Delaware   88-0271109
(State or other jurisdiction of
incorporation or organization)
  (IRS Employer
Identification No.)

 

9300 S. Dadeland Blvd, Ste 600

Miami, FL 33156

(Address of principal executive offices)

 

(305) 670-3370

(Registrant’s telephone number including area code)

 

(Former name, former address and former fiscal year, if changed since last report)

 


  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  ☒  Yes  ☐  No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  ☒  Yes  ☐  No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

☐  Large accelerated filer ☐  Accelerated filer
☐  Non-accelerated filer ☒  Smaller reporting company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ☐  Yes  ☒  No

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: As of November 14, 2019, the issuer had 31,750,106 shares of common stock outstanding.

 

 

 

 

Index to Form 10-Q

 

     
    Page
PART I FINANCIAL INFORMATION 1
     
Item 1. Condensed Consolidated Financial Statements (Unaudited) 1
  Condensed Consolidated Balance Sheets at September 30, 2019 (Unaudited) and December 31, 2018 1
  Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2019 and 2018 (Unaudited) 2
  Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity for the three and nine months ended September 30, 2019 and 2018 (Unaudited)  3
  Condensed Consolidated Statements of Cash Flows for the nine months   ended September 30, 2019 and 2018 (Unaudited) 5
  Notes to Unaudited Condensed Consolidated Financial Statements 6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 12
Item 3. Quantitative and Qualitative Disclosures about Market Risk 14
Item 4. Controls and Procedures 15
     
PART II OTHER INFORMATION 16
     
Item 1. Legal Proceedings 16
Item 1A. Risk Factors 16
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 16
Item 3. Defaults upon Senior Securities 16
Item 4. Mine Safety Disclosures 16
Item 5. Other Information 16
Item 6. Exhibits 18
   
SIGNATURES 19

 

Cautionary Note Regarding Forward-Looking Information

 

This Form 10-Q contains certain statements related to future results of the Company that are considered “forward-looking statements” within the meaning of the Private Litigation Reform Act of 1995. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties, including, but not limited to, changes in political and economic conditions; interest rate fluctuation; competitive pricing pressures within the Company’s market; equity and fixed income market fluctuation; technological changes; changes in law; changes in fiscal, monetary, regulatory, and tax policies; monetary fluctuations as well as other risks and uncertainties detailed elsewhere in this Form 10-Q or from time-to-time in the filings of the Company with the Securities and Exchange Commission. Such forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events.

 

 

 

 

PART I FINANCIAL INFORMATION

 

Item 1. Condensed Consolidated Financial Statements

 

PowerVerde, Inc. and Subsidiary
Condensed Consolidated Balance Sheets
September 30, 2019 (Unaudited) and December 31, 2018
   

 

   2019  2018
Assets          
Current Assets:          
Cash  $32,104   $8,482 
Accounts receivable   9,000    10,000 
 Prepaid expenses and other current assets   19,260    10,866 
Total Current Assets   60,364    29,348 
           
Property and Equipment          
Property and equipment, net of accumulated depreciation of $107,641 and $107,007, respectively       634 
           
Other Assets          
License, net of accumulated amortization of $25,822       74,178 
Total Other Assets       74,178 
Total Assets  $60,364   $104,160 
           
Liabilities and Stockholders’ (Deficit) Equity          
Current Liabilities          
Accounts payable and accrued expenses  $61,057   $39,136 
Total Current Liabilities   61,057    39,136 
           
Long Term Liabilities          
Convertible note payable   281,097     
Total Long Term Liabilities   281,097     
           
Total Liabilities   342,154    39,136 
           
Stockholders’ (Deficit) Equity          
Preferred Stock:          
50,000,000 preferred shares authorized, 0 preferred shares   issued at September 30, 2019 and December 31, 2018        
Common stock:          
200,000,000 common shares authorized, par value $0.0001 per share, 40,300,106 common shares issued and 31,750,106 common shares outstanding at September 30, 2019 and December 31, 2018   3,981    3,981 
Additional paid-in capital   12,689,980    12,609,980 
Treasury stock, 8,550,000 shares at cost   (491,139)   (491,139)
Accumulated deficit   (12,484,612)   (12,057,798)
Total Stockholders’ (Deficit) Equity   (281,790)   65,024 
           
Total Liabilities and Stockholders’ (Deficit) Equity  $60,364   $104,160 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

1 

 

 

PowerVerde, Inc. and Subsidiary
Condensed Consolidated Statements of Operations
For the three and nine months ended September 30, 2019 and 2018
(Unaudited)
   

 

   Three months ended
September 30,
    Nine months ended
September 30,
   2019  2018  2019  2018
             
Revenue  $3,000   $8,000   $9,000   $173,094 
                     
Operating Expenses                    
Research and development   114,620    71,415    184,301    596,128 
General and administrative   49,938    47,511    159,326    181,832 
Total Operating Expenses   164,558    118,926    343,627    777,960 
                     
Loss from Operations   (161,558)   (110,926)   (334,627)   (604,866)
                     
Other Income (Expenses)                    
Interest income               1,621 
Loss on impairment           (69,178)    
Interest expense   (9,265)       (23,009)   (699)
Total Other Income (Expense)   (9,265)       (92,187)   922 
                     
Income (Loss) before Income Taxes   (9,265)   (110,926)   (92,187)   (603,944)
Provision for Income Taxes                
                     
Net Loss  $(170,823)  $(110,926)  $(426,814)  $(603,944)
                     
Net Income (Loss) per Share - Basic and Diluted  $0.01   $0.00   $0.01   $0.02 
                     
Weighted Average Common Shares Outstanding - Basic and Diluted   31,750,106    31,750,106    31,750,106    31,750,106 

  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2 

 

 

PowerVerde, Inc and Subsidiary

Condensed Consolidated Changes in Stockholders’ Equity (Deficit)

For the three and nine months ended September 30, 2019 and 2018

(Unaudited)

 

For the nine months ended September 30, 2019               
   Preferred stock  Common stock  Additional
paid-in
capital
  Accumulated deficit  Treasury stock  Total
Balances at December 31, 2018  $   $3,981   $12,609,980   $(12,057,798)  $(491,139)  $65,024 
Net loss               (426,814)       (426,814)
Stock based compensation             80,000              80,000 
Balances at September 30, 2019  $   $3,981   $12,689,980   $(12,484,612)  $(491,139)  $(281,790)

 

For the three months ended September 30, 2019
   Preferred stock  Common stock  Additional
paid-in
capital
  Accumulated deficit  Treasury stock  Total
Balances at June 30, 2019  $   $3,981   $12,609,980   $(12,313,789)  $(491,139)  $(190,967)
Net loss               (170,823)       (170,823)
Stock based compensation             80,000              80,000 
Balances at September 30, 2019  $   $3,981   $12,689,980   $(12,484,612)  $(491,139)  $(281,790)

 

3 

 

 

PowerVerde, Inc and Subsidiary

Condensed Consolidated Changes in Stockholders’ Equity (Deficit)

For the three and nine months ended September 30, 2019 and 2018

(Unaudited)

 

For the nine months ended September 30, 2018               
   Preferred stock  Common stock  Additional
paid-in
capital
  Accumulated deficit  Treasury stock  Total
Balances at December 31, 2017  $   $3,981   $12,129,331   $(11,378,720)  $(491,139)  $263,453 
Stock based compensation           480,649            480,649 
Net loss               (603,944)       (603,944)
Balances at September 30, 2018  $   $3,981   $12,609,980   $(11,982,664)  $(491,139)  $140,158 

 

For the three months ended September 30, 2018
   Preferred stock  Common stock  Additional
paid-in
capital
  Accumulated deficit  Treasury stock  Total
Balances at June 30, 2018  $   $3,981   $12,574,131   $(11,871,738)  $(491,139)  $215,235 
Stock based compensation           35,849            35,849 
Net loss               (110,926)       (110,926)
Balances at September 30, 2018  $   $3,981   $12,609,980   $(11,982,664)  $(491,139)  $140,158 

 

4 

 

 

PowerVerde, Inc. and Subsidiary
Condensed Consolidated Statements of Cash Flows
For the nine months ended September 30, 2019 and 2018
(Unaudited)

 

   2019  2018
Cash Flows From Operating Activities          
Net loss  $(426,814)  $(603,944)
Adjustments to reconcile net loss to net cash to net cash provided (used) by operating activities:          
Impairment of intangible assets   69,178     
Depreciation and amortization   5,633    16,783 
Amortization of debt issuance costs   5,097     
Stock based compensation   80,000    480,649 
Changes in operating assets and liabilities:          
Accounts receivable and prepaid expenses   (7,393)   350,359 
Accounts payable and accrued expenses   21,921    (92,099)
 Liberty notes receivable       34,000 
           
Cash (Used) Provided by Operating Activities   (252,378)   185,748 
           
Cash Flows from Financing Activities          
Proceeds from notes payable, related party   300,000     
Payment for debt issuance costs   (24,000)    
Payment on notes payable, related party       (150,000)
           
Cash provided by (used in) Financing Activities   276,000    (150,000)
           
Net Change in Cash and Cash Equivalents   23,622    35,748 
           
Cash and Cash Equivalents at Beginning of Period   8,482    1,336 
           
Cash and Cash Equivalents at End of Period  $32,104   $37,084 
           
Supplemental Disclosure of Cash Flow Information          
Cash paid during the period for interest  $10,747   $699 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5 

 


PowerVerde, Inc. and Subsidiary

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2019

 

Note 1 – Condensed Consolidated Financial Statements

 

The accompanying unaudited condensed consolidated financial statements prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report of PowerVerde, Inc. (“PowerVerde,” “we,” “us,” “our,” or the “Company”) as of and for the year ended December 31, 2018. The results of operations for the three and nine months ended September 30, 2019, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of PowerVerde, Inc., formerly known as Vyrex Corporation (the “Company”), and PowerVerde Systems, Inc., formerly known as PowerVerde, Inc., its wholly-owned subsidiary. Intercompany balances and transactions have been eliminated in consolidation.

 

Note 2 – Going Concern

 

We have financed our operations since inception through the sale of debt and equity securities and through Biotech IP licensing revenues which expired March 2018. As of September 30, 2019, we had a working capital deficit of $693 compared to a working capital deficit of $9,788 at December 31, 2018. This decrease in the working capital deficit is due primarily to cash raised through related party debt financing.

 

The Company has historically relied upon unrelated and related party debt and equity financing to fund its cash flow shortages and will require either additional debt or equity financing to sustain its operations. The Company’s revenues through 2018 were derived mainly from royalties under its Biotech licensing agreement, which expired in March 2018. Those factors create substantial doubt about the Company’s ability to continue as a going concern.

 

The Company continues to seek funding from private debt and equity investors, as it needs to promptly raise substantial additional capital in order to finance its plan of operations. There can be no assurance that the Company will be able to promptly raise the necessary funds on commercially acceptable terms, if at all. If the Company does not raise the necessary funds, it may be forced to cease operations.

 

Note 3 – Summary of Significant Accounting Policies

 

Nature of Business

 

The Company is devoting substantially all of its present efforts to establish a new business involving the development and commercialization of clean energy electric power generation systems, and none of its planned principal operations have commenced. However, royalties from licenses unrelated to planned principal operations were recognized as revenue through March 2018, when the underlying license agreement terminated. No revenues from this planned principal operation have been generated.

 

Cash Equivalents

 

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.

 

6 

 

 

Accounts Receivable

 

Accounts receivable consist of balances due from assembly services. The Company monitors accounts receivable and provides allowances when considered necessary. At September 30, 2019 and December 31, 2018, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.

 

Revenue Recognition

 

Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three and nine months ended September 30, 2019 and 2018.

 

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.

 

Impairment of Long-Lived Assets

 

Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses were recognized during the three and nine months ended September 30, 2018. For the nine months ended September 30, 2019, the Company recognized an impairment loss of $69,178.

 

Stock-based Compensation

 

The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

 

Common Stock Purchase Warrants

 

The Company accounts for common stock purchase warrants in accordance with ASC Topic 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASC 815-40”). Based on the provisions of ASC 815-40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company, or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of December 31, 2018 and September 30, 2019 were classified as equity.

 

7 

 

 

Accounting for Uncertainty in Income Taxes

 

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. There is no uncertain tax positions as of September 30, 2019 and December 30, 2018.

 

Research and Development Costs

 

The Company’s research and development costs are expensed in the period in which they are incurred.

 

Earnings (Loss) Per Share

 

Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for 975,000 shares and options for 12,180,500 shares were excluded from weighted average common shares outstanding on a diluted basis.

 

Financial Instruments

 

The Company carries cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and notes payable, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

 

Note 4 – Recent Accounting Pronouncements

 

In February 2016, the FASB issued ASU 2016-02, “Leases,” which created a new Topic, ASC Topic 842 and established the core principle that a lessee should recognize the assets, representing rights-of-use, and liabilities to make lease payments that arise from leases. For leases with a term of 12 months or less, a lessee is permitted to make an election under which such assets and liabilities would not be recognized, and lease expense would be recognized generally on a straight-line basis over the lease term. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018. The Company adopted ASC Topic 842 on January 1, 2019 and such adoption did not have any impact on the Company’s financial statements.

 

In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718).” ASU 2018-07 simplifies the accounting for nonemployee stock-based payment transactions. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018, and early application is permitted. The adoption of this guidance on January 1, 2019 did not have an impact on the Company’s financial statements.

 

8 

 

 

Note 5 – Intellectual Property and License Agreement

 

On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC for total consideration of $100,000 to utilize the Helidyne intellectual property in the manufacturing of planetary rotor expanders and the incorporation of same in the Company’s distributed electric power generation systems. The license agreement also grants the Company an exclusive license to sell the expanders whether manufactured by Helidyne or by the Company. The Company’s royalty obligation begins on the earlier of the commercialization of the product or three years from the effective date of the agreement. Once the royalty obligation begins, the minimum annual royalty is $50,000 for each of the first six years, and $100,000, per commercial year, for the remainder of the agreement. Helidyne has defaulted under the agreement. Royalties would be payable only if Helidyne performs as required, or if the Company elects to produce its own expanders using Helidyne technology. During the quarter ended June 30, 2019, management of the Company evaluated the continued default by Helidyne and determined that Helidyne will not be able to perform under the license agreement for the foreseeable future. The Company’s license agreement continues to be active and the Company may utilize the Helidyne intellectual property in marketing its own products. Under the terms of the license agreement, the Company has the right to develop a prototype utilizing the Helidyne technology at its own cost. Due to the continued default by Helidyne and the potential cost of developing its own prototype, the Company has determined that the intangible asset related to the above license agreement is impaired and recognized an impairment charge of $69,178 in the second quarter of 2019, which is 100% of the net carrying value. See Note 9.

 

For the nine months ended September 30, 2019 and 2018, amortization expense was $5,000 and $9,874, respectively and accumulated amortization of the intangible assets was $25,822 at December 31, 2018.

 

Note 6 – Warrants

 

A summary of warrants issued, exercised and expired during the nine months ended September 30, 2019 is as follows:

 

   Shares  Weighted Average Exercise Price  Intrinsic Value
Balance at December 31, 2018   975,000   $.11     
Issued            
Expired            
Converted to Common Stock Options            
Balance at September 30, 2019   975,000   $.11     

 

Note 7 – Stock Options

 

Stock option activity for the nine months ended September 30, 2019, is summarized as follows:

 

     Shares  Weighted Average Exercise Price  Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2018    11,180,500   $0.20    7.02 
Granted    1,000,000    0.10     
Expired/forfeited              
Options outstanding at September 30, 2019    12,180,500   $0.20    5.85 

 

9 

 

 

Total stock option compensation for the nine months ended September 30, 2019 and 2018 was $80,000 and $480,649, respectively. All of the 2019 options were granted to the Company’s president, who was hired in September 2019. See Note 9. There is no unrecognized compensation expense associated with the options.

 

Note 8 - Convertible Notes Payable to Related Parties

 

In the first quarter of 2019, the Company issued Convertible Promissory Notes totaling $290,000 to stockholders. The notes are to be paid in one principal payment, along with any unpaid interest by December 31, 2021. Interest is payable semiannually at 10%. The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021.

 

In May 2019, the Company issued a Convertible Promissory Note in the principal amount of $10,000 to a stockholder in connection with a loan in the same amount. Consequently, Convertible Promissory Notes have been issued in an aggregate principal amount of $300,000 during the first two quarters of 2019.

 

Long-term debt at September 30, 2019 consisted of the following:

 

   2019
    
Note payable to stockholders  $300,000 
Less: Unamortized debt issuance costs   18,903 
Total long-term debt  $281,097 

 

Amortization of the debt issuance costs is reported as interest expense in the income statement.

 

Note 9 - Commitments and Contingencies

 

On June 25, 2015, Company consultant Hank Leibowitz assigned to the Company a patent he obtained for a system and method for using high temperature sources in Rankine cycle power systems. The Company has agreed to pay Mr. Leibowitz a 2% royalty for any and all revenues of products and/or project sales by the Company based on the subject patent.

 

On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC to utilize the Helidyne intellectual property in order to use Helidyne expanders in Powerverde systems and to sell Helidyne expanders. As part of the licensing agreement the Company committed to purchase two 50 kW expanders, at a price of $25,000 each, on or before the sixth month anniversary of the agreement. The $50,000 was payable in two monthly installments of $25,000 beginning October 2016. The Company had made payments totaling $38,750, towards the purchase of the expanders, all of which was included in prepaid expense and other current assets in the consolidated balance sheets at December 31, 2016. Due to Helidyne’s failure to perform under the agreement, the Company has not made any further payments to Helidyne and does not intend to do so unless and until Helidyne performs as required. Helidyne has not objected to the Company’s position, and it is very unlikely that Helidyne will ever be able to perform.

 

The Company agreed to pay Helidyne LLC a royalty of 3% of sales, subject to a minimum annual royalty of $50,000 beginning on the earlier of commercialization of the product or three years from the effective date of the agreement. This minimum royalty would be payable only if Helidyne performs as required, which is very unlikely, or if the Company elects to produce its own expanders using Helidyne technology. The Company does intend to produce these expanders directly or through a contract manufacturer in the future. See Note 5.

 

10 

 

 

On April 15, 2017, the Company entered into an assembly agreement with Liberty Plugins, Inc. (“Liberty”) to assemble Liberty’s Hydra electronic vehicle charging systems and ship completed Hydras to Liberty’s facility in Santa Barbara, California (the “Liberty Agreement”). Liberty has agreed to pay $1,000 for the first 10 Hydras assembled in a month, $750 per Hydra for the next 10 Hydras assembled per month and $500 per Hydra for each Hydra assembled above 20 per month. The Company has never assembled/shipped more than 10 Hydras in any month and does not expect to do so in the future. As of September 30, 2019, the Company has built and shipped 43 Hydras. Revenue for these products is reflected in the net revenue on the Company’s condensed consolidated statement of operations as follows: $9,000 and $14,000 for the nine months ended September 30, 2019 and 2018, respectively and $3,000 and $8,000 for the three months ended September 30, 2019 and 2018, respectively.

 

On September 1, 2019, the Company hired Daniel Bogar to serve as its President, reporting to the CEO. As compensation, Mr. Bogar received a fully-vested non-qualified option to purchase 1,000,000 shares of the Company’s common stock at an exercise price of $.10 per share, with an expiration date of June 30, 2026. In addition, Mr. Bogar will receive an annual salary of $90,000 beginning on the closing of a private financing with gross proceeds of at least $1,000,000; however, the Company will be permitted to defer the salary to the extent required to maintain solvency.

 

Note 10 - Related Party Transactions

 

Since July 2010, the accounting firm J.L. Hofmann & Associates, P.A. (“JLHPA”), whose principal is our CFO John L. Hofmann, has provided financial consulting and accounting services to the Company. In December 2017, J.L. Hofmann & Associates, P.A. merged with Kabat, Schertzer, De La Torre, Taraboulos & Co, LLC (“KSDT”). The Company paid $30,334 and $28,380 for its services in the nine months ended September 30, 2019 and 2018, respectively and $11,420 and $10,050 in the three months ended September 30, 2019 and 2018, respectively.

 

The Company’s consultant and shareholder Hank Leibowitz receives compensation of $7,500 per month, totaling $67,500 for the first nine months of 2019. At September 30, 2019, Mr. Leibowitz was owed accrued compensation of $30,000.

 

Note 11 – Subsequent Events

 

The Company’s management evaluated subsequent events through November 14, 2019, in connection with the preparation of these condensed consolidated financial statements, which is the date these financial statements were available to be issued. There are no subsequent events to report as of this date.

 

11 

 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward Looking Statements

 

Readers are cautioned that the statements in this Report that are not descriptions of historical facts may be forward-looking statements that are subject to risks and uncertainties. This Report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are based on the beliefs of our management, as well as on assumptions made by and information currently available to us as of the date of this Report. When used in this Report, the words “plan,” “will,” “may,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” “project” and similar expressions are intended to identify such forward-looking statements. Although we believe these statements are reasonable, actual actions, operations and results could differ materially from those indicated by such forward-looking statements as a result of the risk factors included in our 2016 Annual Report, or other factors. We must caution, however, that this list of factors may not be exhaustive and that these or other factors, many of which are outside of our control, could have a material adverse effect on us and our ability to achieve our objectives. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above.

 

The following discussion and analysis should be read in conjunction with the financial statements and notes thereto appearing elsewhere herein.

 

Critical Accounting Policies

 

The condensed consolidated financial statements of PowerVerde, Inc. are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of these condensed consolidated financial statements requires our management to make estimates and assumptions about future events that effect the amounts reported in the financial statements and related notes. Future events and their effects cannot be determined with absolute certainty. Therefore, the determination of estimates requires the exercise of judgment. We believe the following critical accounting policies affect its more significant judgments and estimates used in the preparation of financial statements

 

Accounting for Uncertainty in Income Taxes

 

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

 

Based on our evaluation, we have concluded that there are no significant uncertain tax positions requiring recognition in our condensed consolidated financial statements. Our evaluation was performed for the tax years ended December 31, 2013, 2014, 2015, 2016 and 2017, the tax years which remain subject to examination by major tax jurisdictions as of September 30, 2019.

 

We may from time to time be assessed interest or penalties by major tax jurisdictions, although any such assessments historically have been minimal and immaterial to our financial results. In the event we have received an assessment for interest and/or penalties, it has been classified in the condensed consolidated financial statements as general and administrative expense.

 

Revenue Recognition

 

Revenue from royalties and assembly services unrelated to the Company’s planned operations is recognized when the goods or services are transferred to the customer. Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three and nine months ended September 30, 2019 and 2018.

 

12 

 

 

Common Stock Purchase Warrants

 

The Company accounts for common stock purchase warrants in accordance with ASC Topic 815-40, Derivatives and Hedging – Contracts in Entity’s Own Equity (“ASC 815-40”). Based on the provisions of ASC 815-40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of September 30, 2019 and December 31, 2018 were classified as equity.

 

Intellectual Property

 

The Company reviews intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. In the event of impairment, the Company would discount the future cash flows using its then estimated incremental borrowing rate to estimate the amount of the impairment.

 

Stock-based compensation.

 

We account for stock-based compensation based on ASC Topic 718-Stock Compensation which requires expensing of stock options and other share-based payments based on the fair value of each stock option awarded. The fair value of each stock option is estimated on the date of grant using the Black-Scholes valuation model. This model requires management to estimate the expected volatility, expected dividends, and expected term as inputs to the valuation model.

 

Overview

 

From January 1991 until October 2005, the Company devoted substantially all of its efforts and resources to research and development related to its unsuccessful Biotech Business, in particular the study of biological oxidation and antioxidation directed to the development of potential therapeutic products for the treatment of various diseases and conditions. In the most recent years, the Company’s research focused mainly on targeted antioxidant therapeutics and nutraceuticals. The Company, has generated only limited revenue from product sales and has relied primarily on equity financing, licensing revenues, and various debt instruments for its working capital. The Company has been unprofitable since its inception.

 

Following the cessation of material Biotech Business operations in October 2005, the Company turned its primary focus to seeking an appropriate merger partner for its public shell. This resulted in the February 2008 Merger with Vyrex. In March 2009, we assigned most of our Biotech intellectual property other than our rights under existing licensing agreements (the “Biotech IP”) to an investor in exchange for his agreement to pay all future expenses relating to the Biotech IP and to pay us 20% of any net proceeds received from future sale and/or licensing of the Biotech IP. We do not expect this arrangement to generate material revenues.

 

Since the Merger, we have focused on the development, testing and commercialization of our electric power systems, in particular, their applicability to thermal and natural gas pipeline operations. Our business is subject to significant risks, including the risks inherent in our research and development efforts, uncertainties associated with obtaining and enforcing patents and intense competition. See “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 29, 2019.

 

Except as specifically noted to the contrary, the following discussion relates only to PowerVerde since, as a result of the Merger, the only historical financial statements presented for the Company in periods following the Merger are those of the operating entity, PowerVerde.

 

13 

 

 

Results of Operations

 

Three Months Ended September 30, 2019 as Compared to Three Months Ended September 30, 2018

 

Since inception, we have focused on the development, testing and commercialization of our clean energy Aelectric power generation systems. We had no revenues from sales in the third quarter of 2019 and 2018. Also, we generated $3,000 and $8,000 in revenue for assembly revenues under the Liberty Agreement in the third quarter of 2019 and 2018, respectively. In both years, we had substantial expenses due to our ongoing research and development activities and efforts to commercialize our systems, as well as substantial administrative expenses associated with our status as a public company. Our research and development expenses increased by $43,205 primarily due to the stock options issued in the third quarter of 2019. Our general and administrative expenses increased by $2,427 in the third quarter of 2019 as compared to 2018, primarily because of increased travel expenses. Primarily as a result of stock options issued in the third quarter 2019, our net loss increased by 54% to $170,823 in the third quarter of 2019 from $110,926 in the third quarter of 2018. Substantial net losses are expected until we are able to successfully commercialize and market our systems, as to which there can be no assurance. Any taxes that might result from net income for financial reporting purposes would be eliminated through use of a portion of the Company’s net operating loss carryforward.

 

Nine Months Ended September 30, 2019 as Compared to Nine Months Ended September 30, 2018

 

Since inception, we have focused on the development, testing and commercialization of our clean energy electric power generation systems. We had no revenues from sales in the first nine months of 2019 and 2018 – and we recorded $0 and $159,094 in Biotech IP licensing fees (based on pre-Merger contracts), respectively. Also, we generated $9,000 and 14,000 for assembly revenue under the Liberty Agreement in the first nine months of 2019 and 2018, respectively. In both years, we had substantial expenses due to our ongoing research and development activities and efforts to commercialize our systems, as well as substantial administrative expenses associated with our status as a public company. Our research and development expenses decreased by $411,826 (69.1%) in the first nine months of 2019 as compared to 2018. This decrease is primarily due to the stock options issued in the second quarter of 2018. Our general and administrative expenses decreased by $22,506 (12.4%) in the first nine months of 2019 as compared to 2018, due mainly to the decrease in depreciation and legal fees in 2019. Our net loss was $426,814 and $603,944 in the first nine months of 2019 and 2018, respectively, a 29% reduction. The reduced net loss in 2019 reflects the final Biotech IP revenues received in March 2018 and the issuance of substantial stock options in the second quarter of 2018, the net result of which was more than the value of the stock options issued in the third quarter of 2019. Substantial net losses will continue until we are able to successfully commercialize and market our systems, as to which there can be no assurance. Any taxes that might result from net income for financial reporting purposes would be eliminated through use of a portion of the deficit company’s net operating loss carryforward.

 

Liquidity and Capital Resources

 

We have financed our operations since inception principally through the sale of debt and equity securities. Also, from 2012 through March 2018 we received material amounts of Biotech IP licensing fees. As of September 30, 2019, we had a working capital deficit of $693 compared to a working capital deficit of $9,788 at December 31, 2018. The decrease in working capital deficit is due primarily to loans received from related parties.

 

Our Biotech IP license agreement expired in March 2018 due to the expiration of our underlying patents. Consequently, we have no further material source of revenues. We are generating some revenue by using our employee to provide part-time skilled manufacturing services to third parties; however, we expect this arrangement to generate no more than $5,000 per month. We expect to generate substantial revenue from the 374 Water/Duke project in 2019 if we receive the expected purchase order; however, there can be no assurance that we will receive the purchase order.

 

We continue to seek funding from private equity and debt investors, as we need to promptly raise substantial additional capital in order to finance our plan of operations and commercialize our systems. There can be no assurance that we will be able to promptly raise the necessary funds. If we do not promptly raise the necessary funds, we may be forced to cease operations.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not applicable.

 

14 

 

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and President, evaluated the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.

 

Management’s Annual Report on Internal Control Over Financial Reporting

 

Management of the Company is responsible for establishing and maintaining adequate control over financial reporting. Our internal control system was designed to provide reasonable assurance to our management and Board of Directors regarding the preparation and fair presentation of financial statements.

 

All internal controls over financial reporting, no matter how well designed, have inherent limitations, including the possibility of human error and the circumvention of overriding of controls. Therefore, even effective internal control over financial reporting can provide only reasonable, and not absolute, assurance with respect to financial statement preparation and presentation. Further, because of changes in conditions, the effectiveness of internal controls over financial reporting may vary over time. Because of its inherent limitations, internal controls over financial reporting may also fail to prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.

 

Our Chief Executive Officer and Chief Financial Officer assessed the effectiveness of our internal control over financial reporting as of September 30, 2019. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control—An Integrated Framework. Based on this evaluation, our management concluded that, as of September 30, 2019, our internal control over financial reporting was effective.

 

No Attestation Report

 

This quarterly report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this quarterly report.

 

Changes in Internal Control Over Financial Reporting

 

There were no significant changes in internal control over financial reporting during the third quarter of 2019 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting

 

15 

 

 

PART II OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

None.

 

Item 1A. Risk Factors.

 

There are no material changes to the risk factors set forth in Part I, Item 1A, “Risk Factors,” of the 2018 Annual Report. Please refer to that section for disclosure regarding the risks and uncertainties related to our business.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

In the first quarter of 2019, we issued Convertible Promissory Notes totaling $290,000 to stockholders in connection with a loan in the same amount. The notes are to be paid in one principal payment, along with any unpaid interest, by December 31, 2021. Interest is payable semiannually at 10%. The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021.

 

In the second quarter of 2019, the Company issued a Convertible Promissory Note in the principal amount of $10,000 to a stockholder in connection with a loan in the same amount.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

On September 1, 2019, we hired Daniel Bogar to serve as our President, reporting to our CEO. As compensation, Mr. Bogar received a fully-vested non-qualified option to purchase 1,000,000 shares of our common stock at an exercise price of $.10 per share, with an expiration date of June 30, 2026. In addition, Mr. Bogar will receive an annual salary of $90,000 beginning on the closing of a private financing with gross proceeds of at least $1,000,000; however, the Company will be permitted to defer the salary to the extent required to maintain solvency.

 

Mr. Bogar is an executive with decades of experience in managing, growing and financing companies. From 1987-2000 he served in various management positions with Cellstar Corporation, a pioneer provider of cellular telephone service, in Miami, Florida, and Mexico City, Mexico. In his last position with Cellstar, Mr. Bogar served as President of the Americas region from 1999-2000. From 2000-2009, he served as Managing Director of Stanford Group Holdings (“Stanford”), a wealth management firm based in Houston, Texas. Mr. Bogar served as President/COO of American Green Technology, Inc./Vida Shield (“AGT”), a South Bend, Indiana manufacturer of LED industrial lighting products and anti-microbial lighting products, from inception in 2009 until 2018. Since 2019, Mr. Bogar has served as an adjunct professor of management at the McCoy School of Business, Texas State University, San Marcos, Texas.

 

16 

 

 

On December 18, 2013, the SEC entered a final decision against Mr. Bogar finding that, in connection with his work on behalf of Stanford, which collapsed in 2009, he violated Section 17(a) of the Securities Act of 1933, Sections 10(b) and 15(c)(1) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, and Sections 206(1) and 206(2) of the Investment Advisers Act of 1940. The SEC found Mr. Bogar liable as a result of gross negligence but not willful fraud. Mr. Bogar, his family and friends suffered substantial losses as a result of their investments in Stanford’s securities. Pursuant to the SEC decision, Mr. Bogar was ordered (a) to cease and desist from committing or causing any violations or future violations of the relevant securities laws; (b) barred from association with any broker, dealer, investment adviser, municipal securities dealer, municipal advisor, transfer agent, or nationally recognized statistical rating organization and prohibited, permanently, from serving or acting as an employee, officer, director, member of an advisory board, investment adviser or depositor of, or principal underwriter for, a registered investment company or affiliated person of such investment adviser, depositor, or principal underwriter; (c) to disgorge $1,555,485.75, plus prejudgment interest; and (d) to pay a civil money penalty of $260,000.

 

On August 28, 2018, certain noteholders of AGT unaffiliated with AGT’s majority shareholder Ushio America Inc. (“Ushio”) filed an involuntary chapter 11 petition against AGT in the U.S. Bankruptcy Court for the Southern District of Texas. The petition was granted on October 2, 2018. AGT had run out of cash due to Ushio’s refusal to provide further funding and refusal to extend the maturity of prior financing by Ushio which was secured by AGT’s intellectual property (“IP”) and other assets. On December 18, 2018, the court appointed a trustee for AGT, and on July 11, 2019, the court granted the trustee’s motion to convert the case to a Chapter 7 liquidation.

 

On October 30, 2019, the trustee filed an adversary complaint against Ushio and its affiliates alleging fraud, breach of fiduciary duty and other claims. In essence the trustee alleges that Ushio and its affiliates acted in bad faith in connection with their investment in and control of AGT for the purpose of misappropriating AGT’s IP and other assets. Ushio denies the allegations.

 

On November 6, 2019, PowerVerde and 374Water Inc. (“374”) entered into a memorandum of understanding (the “MOU”) regarding the strategic relationship between the parties whereby they intend for PowerVerde to provide the complete heat recovery system, including an advanced expander, for 374’s Super Critical Water Oxidation (SCWO) system. The MOU is conditioned upon 374 raising sufficient equity capital by March 31, 2020. Part of the contemplated funding will be used to purchase two nominal 60 kWe expanders from PowerVerde at a price to be agreed upon, which is expected to be approximately $500,000. In addition, upon closing of the financing, 374 will issue equity to PowerVerde in the form of restricted stock and stock options. There can be no assurance that 374 will timely raise the required funding or that the contemplated transactions will be profitable for PowerVerde.

 

17 

 

 

Item 6. Exhibits.

 

(a)Exhibits

 

10.25 Memorandum of Understanding dated November 6, 2019, between PowerVerde Inc. and 374Water Inc.
   
31.1 Certification of Principal Executive Officer and Principal Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1 Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2 Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS XBRL INSTANCE DOCUMENT
   
101.SCH XBRL TAXONOMY EXTENSION SCHEMA
   
101.CAL XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
   
101.DEF XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
   
101.LAB XBRL TAXONOMY EXTENSION LABEL LINKBASE
   
101.PRE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

 


 

18 

 

 

SIGNATURES

 

In accordance with Section 13(a) or 15(d) of the Exchange Act, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  POWERVERDE, INC.
     
Dated: November 14, 2019 By: /s/ Richard H. Davis
     
    Richard H. Davis
    Chief Executive Officer
     
Dated: November 14, 2019 By: /s/ John L. Hofmann
     
    John L. Hofmann
    Chief Financial Officer

 

19 

 

 

Exhibit Index

 

Exhibit
No.
 
  Description    
10.25   Memorandum of Understanding dated November 6, 2019, between PowerVerde Inc. and 374Water Inc.
     
31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002  
     
101.INS   XBRL INSTANCE DOCUMENT
     
101.SCH   XBRL TAXONOMY EXTENSION SCHEMA
     
101.CAL   XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
     
101.DEF   XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
     
101.LAB   XBRL TAXONOMY EXTENSION LABEL LINKBASE
     
101.PRE   XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE    

 

 

 

 

EX-10.25 2 ex10_25.htm EXHIBIT 10.25

 

Exhibit 10.25

 

MEMORANDUM OF UNDERSTANDING

 

THIS MEMORANDUM OF UNDERSTANDING (MOU) is dated as of November 06, 2019, between PowerVerde Inc., a Delaware corporation (“PV”) and 374Water Inc., a Delaware corporation (“374”).

 

1. The purpose of this MOU is to define the key terms of a strategic relationship between PV and 374 as it relates to the heat recovery system (HRS) of 374’s Supercritical Water Oxidation (SCWO) system. PV and 374 intend to use commercially reasonable efforts to enter into a contractual relationship to collaborate on the commercial development of the SCWO system.
   
2. The parties’ obligation to negotiate a transaction under the terms of this MOU are conditional upon 374’s raising equity capital on or before March 30, 2020, on terms set by 374’s board of directors (the “Series A Financing”). The date of the closing of the Series A Financing shall be the effective date for purposes of this MOU (the “Effective Date”).
   
3. PV will focus its resources on the development of the complete heat recovery system (HRS) for the SCWO system including the advanced expander. PV will work with 374 to secure funding and to obtain customers for 374’s Nix units.
   
4. 374 will provide PV with the requirements for the HRS for the Nix6 and the Nix30 expander units. 374 may elect to develop different system scales.
   
5. 374 will issue to PV 100 shares of 374’s common stock promptly following closing of the Series A Financing, vesting at the rate of l/12th per month for a year beginning with the first month immediately following the Effective Date, subject to PV’s continued provision of services to 374.
   
6. 374 will also provide PV with an option to purchase after the Effective Date an additional 200 shares at a strike price determined by the valuation of 374’s Series A Financing, such option to be exercisable for a period of 30 days following the earlier of (1) PV’s delivery of a HRS that functions to the satisfaction of 374 or (2) immediately before closing of 374’s second equity financing round.
   
7. 374 will issue to PV a purchase order (PO) for two nominal 60 kWe expanders and to help fund PV’s preliminary design and engineering for the complete HRS, promptly following the Effective Date. The price is anticipated to be in the range of $500,000, but will be mutually acceptable to 374 and PV and will be paid in stages based on milestones reasonably agreed by the parties. Both parties understand there is no HRS specification at this time. Accordingly, the cost to develop the entire HRS is not reflected in the approximate $500,000 price save for some HRS preliminary design and engineering.
   
8. Because of their strategic relationship, the parties will work using an “open book” arrangement. This “esprit de corps” mentality ensures PV in good faith would provide 374 with all internal and contract labor usage and identify the billing rate of each. Materials will be burdened by overhead. All costs incurred in the project will be documented and reported to 374 at regular intervals in arrears, (e.g. weekly or monthly), and 374 will have customary rights to periodically audit the books and records of PV.

 

 

 

 

9. As this is a totally novel system, neither party can know with certainty the final cost in advance, but PV is committed to delivering the HRS with transparency and for significantly less cost than other major companies would charge (e.g., Bechtel or G.E.). PV projects that subsequent purchases of multiple expander units for 374’s Nix6 will cost 374 approximately $50,000 for each unit, PV and 374 will negotiate the purchase price in good faith after the parties have obtained additional information regarding the costs, timelines, and complexity of the delivery of the HRS.
   
10. After delivery and acceptance of the initial two expander units, 374 agrees to reasonably consider entering into a subsequent supplier agreement on mutually agreed-upon terms with PV for the purpose of engineering, fabricating and supplying 374 with complete HRS’s for its SCWO systems going forward.
   
11. In the event that PV is unable or unwilling to provide 374 with expander units going forward, PV will, at 374’s option, grant 374 the rights to manufacture or have manufactured the expander units under the terms of PV’s license agreement with Ranator A.B.
   
12. The parties will maintain the strict confidentiality of all non-public information relating to the proposed transactions and operations set forth in this MOU.
   
13. The parties will use their best efforts to draft, negotiate and execute on or before December 31, 2019, definitive agreements for the proposed transactions, consistent with the terms of this MOU and containing other language which is customary for comparable transactions. This MOU and all of the agreements will be governed by the laws of the State of Delaware.

 

POWERVERDE INC.   374WATER INC.
     
By:     By:  
  Richard H.Davis, CEO     Yaacov Nagar, CEO

 

11/6/2019

 

 

 

EX-31.1 3 ex31_1.htm EXHIBIT 31.1

 

  

Exhibit 31.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard H. Davis, certify that:

 

1.I have reviewed this Form 10-Q of PowerVerde, Inc.

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: November 14, 2019 /s/ Richard H. Davis    
    Richard H. Davis, Chief Executive Officer

 

 

 

EX-31.2 4 ex31_2.htm EXHIBIT 31.2

 

  

 Exhibit 31.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, John L. Hofmann, certify that:

 

1.I have reviewed this Form 10-Q of PowerVerde, Inc.

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: November 14, 2019 /s/ John L. Hofmann    
    John L. Hofmann, Chief Financial Officer

 

 

 

EX-32.1 5 ex32_1.htm EXHIBIT 32.1

 

  

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard H. Davis, certify as follows:

 

1.To the best of my knowledge, the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, fully complies in all material respects with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

 

2.To the best of my knowledge, based upon a review of the report, the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

By: /s/ Richard H. Davis      
  Richard H. Davis
  Chief Executive Officer
November 14, 2019

 

 

 

EX-32.2 6 ex32_2.htm EXHIBIT 32.2

 

  

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, John L. Hofmann, certify as follows:

 

1.To the best of my knowledge, the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, fully complies in all material respects with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

 

2.To the best of my knowledge, based upon a review of the report, the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

By: /s/ John L. Hofmann    
  John L. Hofmann
  Chief Financial Officer
November 14, 2019

 

 

 

GRAPHIC 7 img_001.jpg GRAPHIC begin 644 img_001.jpg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end GRAPHIC 8 img_002.jpg GRAPHIC begin 644 img_002.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" Y (0# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^[#XR?$S0 M/@K\(/BK\8_%=W;6'A?X2_#?QS\3/$E]>R^19V>@> _#&J>*=8N[N;_EC;6^ MG:5K>(O%UQ\2/B+X-TOX@_$$Z]K&MZAJFI7=_%XQ\3ZW!(LM[)#:K$E MG8I;V-O;6T/FW_!:"]\53_\ !-/]I?X<> DAN/'G[2.G_#G]CSP;8RW=O9M? MZ_\ MD_%[P#^R[;P0R7,L,3O#;?%JZOID:18Q9VES+<%+:*>1/TYT[3[+2=/ ML=*TVW2TT[3+.VT^PM8MWEVUG90);6MO'N+-LA@B2-=S,VU1DDY- %RBO'A^ MT-\ S\9S^SBOQL^$K?M"+X:/C-_@6OQ%\(-\7T\(!8W_ .$HD^&RZP?&,?A\ MQRQRKJ[Z.MBT+>';=M#U99?#WC3]J7 MXK:4CS?"#X2ZF+RW\+^'IT^,GQ.TE? J^&-+\<_G;^UG^UAXZL_^"N'Q \'? MLR:9HOQ)_:V\"_LQ_";]A[]ESX<>-W>U^&_ACXP?M4>+[C]J']K3]H3XIMI^ MHMXDG^#?[,/[-OPL_92\=?$"?PQIPU[6-7^('@WX4:7)'KGQ3\/7UG^WG['_ M .R9\-OV,?@Q8_"+X>7&M^(]0U+Q'XE^(_Q8^*WC:XM]6^*?QX^-7CV_.L?$ M?XU?%WQ1%;V\_BKX@^-M6*->:C<@P:/H.G^'_!OAZ#3/"/A?P[HVF@'Y7^+? MV/\ ]G#]B_\ :I_X(Q?"WX*>%)X/%NM?MA_M:^/?'/Q1\7ZC>^-?C9\:_$>J M?\$\?VNKCXI?%GXY?%;6C<^*_B3\0/&'BC7/#-QK7B/Q'>2Q6KS:5X>\-VGA M[PMI6@^'M._?*OR<^'"WG[2W_!6CX[?$R[FN_P#A6G_!.+X,Z%^RO\/-/:TL M9=,UK]I#]JO1_ /[0G[1'B^'58+AKIY? _P5TC]F/P#H]C+%MM-0\:?%"*Y2 M.86AK]8Z "BOE7]K7]LCX+_L9> M+\8_%6Z\2Z[XC\9ZTG@[X/?!?X9:!+XY M^.7Q\^)%W"9-(^&?P7^'-E/;7WB[Q=JLABC:2>ZTGPMX;M93KOC;Q+X7\,VM M_K=I\7+^SC^WY^VWH]]KW[6?[0OQ"_8!^'FH7Z:AX"_9>_8/^(&@Z3\:]'TB M;3=*>W;]IK]L2\T+QA<^(O&]CJ8U='\"_LNZ=\-/AQX?W_9-5^)7QUM38:II MP!^O=%?C=IO[3G[2?_!.J;5?AY^W1X7^*W[2'[+6A7\W_"IO^"B/PD\!ZC\4 M?&_AWX=1Z7J&H6OA[]OKX*?"[P\WC7PWX^\%C35\/W/[2'P7\ ^*OA+\5+.\ MT;Q9XY\,? OQ"^NZ7=]!'_P6J_8[\:=:7'AG] MD_\ 9(^.OC*ULO[4CU)K2YUKXI>._"'PV^ GA>U-QIDMC*_BOXMZ%)#=30^; M$ELEW(/%'B2^TW0]&LA--%$;K4;ZV@$LL:SX1\3_"+X6:_;Z7IUC+K'P<_9 M<\ >#/AY^S-\/]:%QIZ7VG>-Q\*M;^*^FRR2 ?$BY::YDG /-YO^"D/QE_:B MMK:Q_P""6_[*^O?M ^'-63RXOVQ?VE9_%7[+_P"Q7I,5U9>(!::WX,O_ !+X M3N_C[^TS:6^KZ+;VWGACX"^%]:B%[X0^%?A;3Y;1/B;^U5\<%AD-QI'P2^ M!6A7C:M=QQVUYJ7Q&^(=WX(^$WAFPN]5\7RW6E 'S1_P2/\ A3X<^%WQ3_X* M7:1\"K_QA8_L:^%_VL/#WP8_9^\#>*?'7Q,^(=II'C_X)_!WP9X8_:N\3^&O M$/Q;USQ5XODT[5?C_?>)/AYJDZ[K/A[X9>'7L+KQ7XKU"75?&/Q \8:WJ>H>*?B)\ M3_&^J3,S:EXY^*/Q!UWQ/\0_&M^@BM[OQ1XFU:>UMK6U>&VB^B* "BBB@ HH MHH _([_@G=^P'K7P9^/'[:7[?'[2&B>'+K]M/]M'XT>-4U.]L)-/\2)\'OV7 M?A]XB'@C]GCX*>#_ !M&3<:MI^I_#/P-\/O'/Q UBTT_P@WB;71X3T'Q%X4@ MNOA=HUQ7ZXT44 ?@#_P3]_;2_82_98\(?M8^#OVEOVK/V9OV:OVF?$W_ 42 M_;Z^)GQZ^%GQR^-GPY^$WQ%M-8\1_M*>/+?X4ZT/#WQ"\0>'?$7B;PKKG[-6 MC? ^Z^'?B_3+75M!\0^!_P#A'8_#^JWEI:)!;?0.M?\ !3GQ#^TM&G@;_@E1 M\'-9_:M\4:Y%K%I_PU5\1/#'CWX7?\$^_A*]A)%ILWB+Q'\:-=T?0-4_:,OM M+U*_T^YMOA7^RO;^.M7\26\.I6FM>._AG:6MSXBL_P!:;_1-'U26VGU'2]/O MI[.1);.XNK2":XM)$;>KVL[H9K=@V:Y^T=\9_B5XI_:T_;8\<>'K7POXU_:C^*>GV6G7N@^$H9);Y_A5 M^SS\,M.N;[P?^S9\#UUJ\U'6O^%=^ 'EU+Q%J=[_ &M\3/&?Q%U^TLM:M_T# MHHH */\ /^?2DQR#D\9XSP)_V M8/\ @FO\&Q^WS^VUIS^+OC2/P_J&BVT'A!]1TK7I #Z>_;,_;.M?V:;7P7 M\-OAIX'N_CW^UY\<;B]T7]G7]FSP[J<>G:MXPOK)H(M;^(/Q UP6U_'\,O@+ M\.$N[;5?BE\6-;LVTK0;%[;1M)@UOQCK?AWP[JGY9?LX?M-? 3]GGQQ\4[KP M1JGQ;_X+ ?\ !3SXN:KH6F?M*^/OV-_ARGCGX;?#_4WOM?A\%_L^1?'37]=T M?]F']DWX!?"34;'7+/3/AKX_^.>F^.;&X;5_B'X[T+7?&WBQ6OO.O@5_P;^_ M%#XI^+?B7\=_^"J/[O@C^S9XD\0?!C]G3QKX1\/7' MC&32O@'X[\43(/C!\2O@+X=3Q+9-X8^'OA*\_9^\#V\^CVU_XD\#>+?$QN/% MEW_2%\//AQ\//A'X,T#X%O ?P\\+Z'X+\&>&M/\ M-DG^P:!X7\-V.FZ'H]GY\TTWV73K&V@\V6239OD8D _,4^'_ /@L9^TOIHN= M:^('[,__ 3#\):BFD7=OX;^'/AH_MU?M0V*6\S'5;#5OB3\08OAG^S'X*O= M2CP&LM*^#'Q\LM/C$8M/%EW-+));^;_\$E_#WQSU[XI_MX?&#Q9^V'^U+^TC M^SE8_M!:U^S1^S7IO[1$=/\ "_A/P[HUOH_PAU#5M1N_'!U[PY=^%?VUK\COB!_P2%\$ZU\; M/B/\:O@?^VU_P4,_8T'Q:UK4/&'C[X/?LJ_';P-X6_9_UGXD^(+HW_C7XJVO MPC^)7P<^*OAW0/B+\0M1$6J^/?$/AQ=(/B?6UN->O[5M;U;7-0U0 _7&OG?Q MK^U[^R;\-OB7X;^"WQ%_:@_9W\ _&+QCK.B>'/"/PF\:_&OX:^%OB7XJ\0^) M;NRT_P .:#X;\":[XFL/%.N:SX@O]3TVRT32],TJZOM5N]0LK:P@GFNX$D_) M_P 4_P#!O[\$_BQ/KT?[2/[??_!67]J+P[XDN_M6H^ ?C/\ MLZE'\.4BFE4 MZIIMAX&^%G@+X8^'=-TG6K0/INH:=8V,%M'832IIJ:=.4N$]&_:O_P""1_P> MF^%/PGM/^"?G[-/[%7[/_P 5_@[^T[^SG^T?9QM\,=/^#/AOXEC]G?QE:>/= M(\">.O'_ ,&O 6L>,X]/\0>(=$\.-J^KZKX9\>>=9V%RTFCRZQ+I^LZ8 ?M% M17YYZ7\9O^"FC-J<'B#]@O\ 9AM+BRU.:TLKGPW_ ,%"O%>OZ1J^G)!;21:M M:W.L_L,>#]6MDGN);FW%EJ.@VEU&MJLSC%PJ(4 ?H91110 4444 %%%% !7C MGQ_^+=W\#/A'XQ^)^F_"_P")WQIUCPY:6:Z%\*_@]X='B?XA>.-?U?4[+1-$ MT+0[*:YL=,L(KG4]1M6U?Q)X@U+2O#/A;18]0\1>(M4L-(TR[N$]CJO%_K+C M_KX7_P!)(* /YW/A1^S5_P %)?\ @I[XXO\ ]@;]CRXU@Z'H M'_!.3]E7XD^&+[XD_%/PS:S7,LS_ +0'[:'PHU27QNG@WQ%I-\?#/BKPE\'_ M !EX.@^)6FR7B:GH/PM33!:^*OV^_9Y_9Q^!7[*'PG\+_ W]G+X5^$?@Y\*/ M!MN;?0?!G@W3(]/L$E=8Q=ZOJ=TTESJ?B'Q)J\D:W>O>*O$5_JGB;Q#J#2ZE >KNJW^H3S7,GMM% !1110 4444 %%%% !1110!__9 end EX-101.INS 9 pwvi-20190930.xml XBRL INSTANCE FILE 0000933972 2018-12-31 0000933972 2019-01-01 2019-09-30 0000933972 2019-09-30 0000933972 2018-01-01 2018-09-30 0000933972 2019-11-14 0000933972 2017-12-31 0000933972 2019-07-01 2019-09-30 0000933972 2018-07-01 2018-09-30 0000933972 2018-09-30 0000933972 2019-06-30 0000933972 us-gaap:WarrantMember 2019-01-01 2019-09-30 0000933972 us-gaap:OptionMember 2019-01-01 2019-09-30 0000933972 pwvi:HelidyneLLCMember 2016-05-30 2016-06-01 0000933972 pwvi:HelidyneLLCMember 2016-06-01 0000933972 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0000933972 us-gaap:EmployeeStockOptionMember 2018-12-31 0000933972 2019-05-31 0000933972 2019-01-01 2019-03-31 0000933972 2015-06-25 0000933972 2016-10-01 0000933972 us-gaap:EmployeeStockOptionMember 2019-09-30 0000933972 pwvi:HankLeibowitzMember 2019-01-01 2019-09-30 0000933972 pwvi:HankLeibowitzMember 2019-09-30 0000933972 srt:ChiefExecutiveOfficerMember pwvi:DanielBogarMember 2019-08-30 2019-09-01 0000933972 2019-03-31 0000933972 us-gaap:PreferredStockMember 2018-01-01 2018-09-30 0000933972 us-gaap:PreferredStockMember 2018-07-01 2018-09-30 0000933972 us-gaap:PreferredStockMember 2019-01-01 2019-09-30 0000933972 us-gaap:PreferredStockMember 2019-07-01 2019-09-30 0000933972 us-gaap:PreferredStockMember 2017-12-31 0000933972 us-gaap:PreferredStockMember 2018-09-30 0000933972 us-gaap:PreferredStockMember 2018-06-30 0000933972 us-gaap:PreferredStockMember 2018-12-31 0000933972 us-gaap:PreferredStockMember 2019-09-30 0000933972 us-gaap:PreferredStockMember 2019-06-30 0000933972 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0000933972 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0000933972 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0000933972 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0000933972 us-gaap:CommonStockMember 2017-12-31 0000933972 us-gaap:CommonStockMember 2018-09-30 0000933972 us-gaap:CommonStockMember 2018-06-30 0000933972 us-gaap:CommonStockMember 2018-12-31 0000933972 us-gaap:CommonStockMember 2019-09-30 0000933972 us-gaap:CommonStockMember 2019-06-30 0000933972 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0000933972 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0000933972 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0000933972 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000933972 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000933972 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000933972 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000933972 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000933972 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000933972 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000933972 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0000933972 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0000933972 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0000933972 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000933972 us-gaap:RetainedEarningsMember 2017-12-31 0000933972 us-gaap:RetainedEarningsMember 2018-09-30 0000933972 us-gaap:RetainedEarningsMember 2018-06-30 0000933972 us-gaap:RetainedEarningsMember 2018-12-31 0000933972 us-gaap:RetainedEarningsMember 2019-09-30 0000933972 us-gaap:RetainedEarningsMember 2019-06-30 0000933972 us-gaap:TreasuryStockMember 2018-01-01 2018-09-30 0000933972 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0000933972 us-gaap:TreasuryStockMember 2019-01-01 2019-09-30 0000933972 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000933972 us-gaap:TreasuryStockMember 2017-12-31 0000933972 us-gaap:TreasuryStockMember 2018-09-30 0000933972 us-gaap:TreasuryStockMember 2018-06-30 0000933972 us-gaap:TreasuryStockMember 2018-12-31 0000933972 us-gaap:TreasuryStockMember 2019-09-30 0000933972 us-gaap:TreasuryStockMember 2019-06-30 0000933972 2018-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 10-Q 2019-09-30 false 0000933972 --12-31 Yes 2019 Q3 POWERVERDE, INC. 50000000 50000000 0 0 0 0 0.0001 0.0001 200000000 200000000 8550000 8550000 31750106 Non-accelerated Filer false true 000-27866 Yes NV 107007 107641 25822 25822 40300106 40300106 31750106 31750106 -9788 -693 1.00 1.00 1.00 1.00 -69178 0 975000 12180500 5000 9874 25822 100000 50000 11180500 12180500 1000000 0.20 0.20 0.10 P7Y7D P5Y10M6D 0 300000 300000 10000 290000 18903 281097 2021-12-31 0.10 The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021. 0.03 0.02 38750 50000 25000 25000 9000 14000 3000 8000 30334 28380 10050 11420 975000 975000 0.11 0.11 false 67500 30000 1000000 .10 90000 2026-06-30 29348 60364 10866 19260 10000 9000 8482 32104 634 0 104160 60364 74178 0 74178 0 39136 61057 39136 61057 39136 342154 0 281097 0 281097 0 0 104160 60364 65024 -281790 263453 140158 -190967 3981 3981 3981 3981 3981 3981 12129331 12609980 12574131 12609980 12689980 12609980 -11378720 -11982664 -11871738 -12057798 -12484612 -12313789 -491139 -491139 -491139 -491139 -491139 -491139 215235 -12057798 -12484612 491139 491139 12609980 12689980 3981 3981 9000 173094 3000 8000 -334627 -604866 -161558 -110926 343627 777960 164558 118926 159326 181832 49938 47511 184301 596128 114620 71415 69178 0 0 0 0 1621 0 0 23009 699 9265 0 -92187 922 -9265 0 31750106 31750106 31750106 31750106 0.01 0.02 0.01 0.00 -426814 -603944 -170823 -110926 -603944 -110926 -426814 -170823 0 0 0 0 -92187 -603944 -9265 -110926 80000 480649 80000 35849 480649 35849 80000 80000 5097 0 5633 16783 69178 0 -252378 185748 0 -34000 21921 -92099 7393 -350359 8482 32104 1336 37084 23622 35748 276000 -150000 0 150000 24000 0 300000 0 10747 699 <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Note 1 &#8211; Condensed Consolidated Financial Statements</p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report of PowerVerde, Inc. (&#8220;PowerVerde,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or the &#8220;Company&#8221;) as of and for the year ended December 31, 2018. The results of operations for the three and nine months ended September 30, 2019, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of PowerVerde, Inc., formerly known as Vyrex Corporation (the &#8220;Company&#8221;), and PowerVerde Systems, Inc., formerly known as PowerVerde, Inc., its wholly-owned subsidiary. Intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 &#8211; Going Concern</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have financed our operations since inception through the sale of debt and equity securities and through Biotech IP licensing revenues which expired March 2018. As of September 30, 2019, we had a working capital deficit of $693 compared to a working capital deficit of $9,788 at December 31, 2018. This decrease in the working capital deficit is due primarily to cash raised through related party debt financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has historically relied upon unrelated and related party debt and equity financing to fund its cash flow shortages and will require either additional debt or equity financing to sustain its operations. The Company&#8217;s revenues through 2018 were derived mainly from royalties under its Biotech licensing agreement, which expired in March 2018. Those factors create substantial doubt about the Company&#8217;s ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company continues to seek funding from private debt and equity investors, as it needs to promptly raise substantial additional capital in order to finance its plan of operations. There can be no assurance that the Company will be able to promptly raise the necessary funds on commercially acceptable terms, if at all. If the Company does not raise the necessary funds, it may be forced to cease operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 &#8211; Summary of Significant Accounting Policies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Nature of Business</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is devoting substantially all of its present efforts to establish a new business involving the development and commercialization of clean energy electric power generation systems, and none of its planned principal operations have commenced. However, royalties from licenses unrelated to planned principal operations were recognized as revenue through March 2018, when the underlying license agreement terminated. No revenues from this planned principal operation have been generated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash Equivalents</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable consist of balances due from assembly services. The Company monitors accounts receivable and provides allowances when considered necessary. At September 30, 2019 and December 31, 2018, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three and nine months ended September 30, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Property and Equipment</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Impairment of Long-Lived Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses were recognized during the three and nine months ended September 30, 2018. For the nine months ended September 30, 2019, the Company recognized an impairment loss of $69,178.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-based Compensation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#8211; &#8220;Stock Compensation&#8221; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Purchase Warrants</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for common stock purchase warrants in accordance with ASC Topic 815-40, &#8220;Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity&#8221; (&#8220;ASC 815-40&#8221;). Based on the provisions of ASC 815-40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company, or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of December 31, 2018 and September 30, 2019 were classified as equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Accounting for Uncertainty in Income Taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#160;follows the provisions of ASC Topic 740-10, &#8220;Accounting for Uncertainty in Income Taxes&#8221; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. There is no uncertain tax positions as of September 30, 2019 and December 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Research and Development Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s research and development costs are expensed in the period in which they are incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Earnings (Loss) Per Share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#8220;Earnings per Share&#8221;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for <font style="color: black">975,000 </font>shares and options for 12,180,500 shares were excluded from weighted average common shares outstanding on a diluted basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Financial Instruments</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company carries cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and notes payable, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Use of Estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 4 &#8211; Recent Accounting Pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02, &#8220;<i>Leases,&#8221; </i>which created a new Topic, ASC Topic 842 and established the core principle that a lessee should recognize the assets, representing rights-of-use, and liabilities to make lease payments that arise from leases. For leases with a term of 12 months or less, a lessee is permitted to make an election under which such assets and liabilities would not be recognized, and lease expense would be recognized generally on a straight-line basis over the lease term. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018. The Company adopted ASC Topic 842 on January 1, 2019 and such adoption did not have any impact on the Company&#8217;s financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2018, the FASB issued ASU 2018-07, <i>&#8220;Compensation &#8211; Stock Compensation (Topic 718).&#8221;</i> ASU 2018-07 simplifies the accounting for nonemployee stock-based payment transactions. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018, and early application is permitted. The adoption of this guidance on January 1, 2019 did not have an impact on the Company&#8217;s financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 5 &#8211; Intellectual Property and License Agreement</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC for total consideration of $100,000 to utilize the Helidyne intellectual property in the manufacturing of planetary rotor expanders and the incorporation of same in the Company&#8217;s distributed electric power generation systems. The license agreement also grants the Company an exclusive license to sell the expanders whether manufactured by Helidyne or by the Company. The Company&#8217;s royalty obligation begins on the earlier of the commercialization of the product or three years from the effective date of the agreement. Once the royalty obligation begins, the minimum annual royalty is $50,000 for each of the first six years, and $100,000, per commercial year, for the remainder of the agreement. Helidyne has defaulted under the agreement. Royalties would be payable only if Helidyne performs as required, or if the Company elects to produce its own expanders using Helidyne technology. During the quarter ended June 30, 2019, management of the Company evaluated the continued default by Helidyne and determined that Helidyne will not be able to perform under the license agreement for the foreseeable future. The Company&#8217;s license agreement continues to be active and the Company may utilize the Helidyne intellectual property in marketing its own products. Under the terms of the license agreement, the Company has the right to develop a prototype utilizing the Helidyne technology at its own cost. Due to the continued default by Helidyne and the potential cost of developing its own prototype, the Company has determined that the intangible asset related to the above license agreement is impaired and recognized an impairment charge of $69,178 in the second quarter of 2019, which is 100% of the net carrying value. See Note 9.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the nine months ended September 30, 2019 and 2018, amortization expense was $5,000 and $9,874, respectively and accumulated amortization of the intangible assets was $25,822 at December 31, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 6 &#8211; Warrants</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of warrants issued, exercised and expired during the nine months ended September 30, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding: 0 0 0 10; text-indent: -10">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Intrinsic Value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; padding: 0 0 0 10; text-indent: -10">Balance at December 31, 2018</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">975,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">.11</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0 0 0 10; text-indent: -10">Issued</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0 0 0 10; text-indent: -10">Expired</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding: 0 0 0 10; text-indent: -10">Converted to Common Stock Options</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0 0 0 10; text-indent: -10">Balance at September 30, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">975,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">.11</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 7 &#8211; Stock Options</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock option activity for the nine months ended September 30, 2019, is summarized as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left"><b>&#160;</b></td> <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><b>Shares</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><b>Weighted Average Exercise Price</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><b>Weighted Average Remaining Contractual Life (Years)</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 45%; font-weight: bold; text-align: left"><b>Options outstanding at December 31, 2018</b></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">11,180,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">0.20</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">7.02</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.10</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expired/forfeited</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><b>Options outstanding at September 30, 2019</b></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,180,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.20</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5.85</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total stock option compensation for the nine months ended September 30, 2019 and 2018 was $80,000 and $480,649, respectively. All of the 2019 options were granted to the Company&#8217;s president, who was hired in September 2019. See Note 9. There is no unrecognized compensation expense associated with the options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 8 - Convertible Notes Payable to Related Parties</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the first quarter of 2019, the Company issued Convertible Promissory Notes totaling $290,000 to stockholders. The notes are to be paid in one principal payment, along with any unpaid interest by December 31, 2021. Interest is payable semiannually at 10%. The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2019, the Company issued a Convertible Promissory Note in the principal amount of $10,000 to a stockholder in connection with a loan in the same amount. Consequently, Convertible Promissory Notes have been issued in an aggregate principal amount of $300,000 during the first two quarters of 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-term debt at September 30, 2019 consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Note payable to stockholders</td><td style="width: 10%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">300,000</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Unamortized debt issuance costs</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,903</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total long-term debt</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">281,097</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization of the debt issuance costs is reported as interest expense in the income statement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 9 - Commitments and Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2015, Company consultant Hank Leibowitz assigned to the Company a patent he obtained for a system and method for using high temperature sources in Rankine cycle power systems. The Company has agreed to pay Mr. Leibowitz a 2% royalty for any and all revenues of products and/or project sales by the Company based on the subject patent.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC to utilize the Helidyne intellectual property in order to use Helidyne expanders in Powerverde systems and to sell Helidyne expanders. As part of the licensing agreement the Company committed to purchase two 50 kW expanders, at a price of $25,000 each, on or before the sixth month anniversary of the agreement. The $50,000 was payable in two monthly installments of $25,000 beginning October 2016. The Company had made payments totaling $38,750, towards the purchase of the expanders, all of which was included in prepaid expense and other current assets in the consolidated balance sheets at December 31, 2016. Due to Helidyne&#8217;s failure to perform under the agreement, the Company has not made any further payments to Helidyne and does not intend to do so unless and until Helidyne performs as required. Helidyne has not objected to the Company&#8217;s position, and it is very unlikely that Helidyne will ever be able to perform.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company agreed to pay Helidyne LLC a royalty of 3% of sales, subject to a minimum annual royalty of $50,000 beginning on the earlier of commercialization of the product or three years from the effective date of the agreement. This minimum royalty would be payable only if Helidyne performs as required, which is very unlikely, or if the Company elects to produce its own expanders using Helidyne technology. The Company does intend to produce these expanders directly or through a contract manufacturer in the future. See Note 5.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 15, 2017, the Company entered into an assembly agreement with Liberty Plugins, Inc. (&#8220;Liberty&#8221;) to assemble Liberty&#8217;s Hydra electronic vehicle charging systems and ship completed Hydras to Liberty&#8217;s facility in Santa Barbara, California (the &#8220;Liberty Agreement&#8221;). Liberty has agreed to pay $1,000 for the first 10 Hydras assembled in a month, $750 per Hydra for the next 10 Hydras assembled per month and $500 per Hydra for each Hydra assembled above 20 per month. The Company has never assembled/shipped more than 10 Hydras in any month and does not expect to do so in the future. As of September 30, 2019, the Company has built and shipped 43 Hydras. Revenue for these products is reflected in the net revenue on the Company&#8217;s condensed consolidated statement of operations as follows: $9,000 and $14,000 for the nine months ended September 30, 2019 and 2018, respectively and $3,000 and $8,000 for the three months ended September 30, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 1, 2019, the Company hired Daniel Bogar to serve as its President, reporting to the CEO. As compensation, Mr. Bogar received a fully-vested non-qualified option to purchase 1,000,000 shares of the Company&#8217;s common stock at an exercise price of $.10 per share, with an expiration date of June 30, 2026. In addition, Mr. Bogar will receive an annual salary of $90,000 beginning on the closing of a private financing with gross proceeds of at least $1,000,000; however, the Company will be permitted to defer the salary to the extent required to maintain solvency.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 10 - Related Party Transactions</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since July 2010, the accounting firm J.L. Hofmann &#38; Associates, P.A. (&#8220;JLHPA&#8221;), whose principal is our CFO John L. Hofmann, has provided financial consulting and accounting services to the Company. In December 2017, J.L. Hofmann &#38; Associates, P.A. merged with Kabat, Schertzer, De La Torre, Taraboulos &#38; Co, LLC (&#8220;KSDT&#8221;). The Company paid $30,334 and $28,380 for its services in the nine months ended September 30, 2019 and 2018, respectively and $11,420 and $10,050 in the three months ended September 30, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s consultant and shareholder Hank Leibowitz receives compensation of $7,500 per month, totaling $67,500 for the first nine months of 2019. At September 30, 2019, Mr. Leibowitz was owed accrued compensation of $30,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 11 &#8211; Subsequent Events</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s management evaluated subsequent events through November 14, 2019, in connection with the preparation of these condensed consolidated financial statements, which is the date these financial statements were available to be issued. There are no subsequent events to report as of this date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Nature of Business</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is devoting substantially all of its present efforts to establish a new business involving the development and commercialization of clean energy electric power generation systems, and none of its planned principal operations have commenced. However, royalties from licenses unrelated to planned principal operations were recognized as revenue through March 2018, when the underlying license agreement terminated. No revenues from this planned principal operation have been generated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash Equivalents</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable consist of balances due from assembly services. The Company monitors accounts receivable and provides allowances when considered necessary. At September 30, 2019 and December 31, 2018, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three and nine months ended September 30, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Property and Equipment</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Impairment of Long-Lived Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses were recognized during the three and nine months ended September 30, 2018. For the nine months ended September 30, 2019, the Company recognized an impairment loss of $69,178.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-based Compensation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#8211; &#8220;Stock Compensation&#8221; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Purchase Warrants</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for common stock purchase warrants in accordance with ASC Topic 815-40, &#8220;Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity&#8221; (&#8220;ASC 815-40&#8221;). Based on the provisions of ASC 815-40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company, or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of December 31, 2018 and September 30, 2019 were classified as equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Accounting for Uncertainty in Income Taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#160;follows the provisions of ASC Topic 740-10, &#8220;Accounting for Uncertainty in Income Taxes&#8221; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. There is no uncertain tax positions as of September 30, 2019 and December 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Research and Development Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s research and development costs are expensed in the period in which they are incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Earnings (Loss) Per Share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#8220;Earnings per Share&#8221;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for <font style="color: black">975,000 </font>shares and options for 12,180,500 shares were excluded from weighted average common shares outstanding on a diluted basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Financial Instruments</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company carries cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and notes payable, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Use of Estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of warrants issued, exercised and expired during the nine months ended September 30, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding: 0 0 0 10; text-indent: -10">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Intrinsic Value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; padding: 0 0 0 10; text-indent: -10">Balance at December 31, 2018</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">975,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">.11</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0 0 0 10; text-indent: -10">Issued</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0 0 0 10; text-indent: -10">Expired</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding: 0 0 0 10; text-indent: -10">Converted to Common Stock Options</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0 0 0 10; text-indent: -10">Balance at September 30, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">975,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">.11</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock option activity for the nine months ended September 30, 2019, is summarized as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left"><b>&#160;</b></td> <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><b>Shares</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><b>Weighted Average Exercise Price</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><b>Weighted Average Remaining Contractual Life (Years)</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 45%; font-weight: bold; text-align: left"><b>Options outstanding at December 31, 2018</b></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">11,180,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">0.20</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">7.02</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0.10</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expired/forfeited</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><b>Options outstanding at September 30, 2019</b></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,180,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.20</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5.85</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-term debt at September 30, 2019 consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Note payable to stockholders</td><td style="width: 10%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">300,000</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Unamortized debt issuance costs</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,903</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total long-term debt</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">281,097</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table> EX-101.SCH 10 pwvi-20190930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Changes in Stockholders' Equity (Deficit) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Condensed Consolidated Financial Statements link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Intellectual Property and License Agreement link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stock Options link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Convertible Notes Payable to Related Parties link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Stock Options (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Convertible Notes Payable to Related Parties (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Intellectual Property and License Agreement (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Stock Options (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Convertible Notes Payable to Related Parties (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Convertible Notes Payable to Related Parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 pwvi-20190930_cal.xml XBRL CALCULATION FILE EX-101.DEF 12 pwvi-20190930_def.xml XBRL DEFINITION FILE EX-101.LAB 13 pwvi-20190930_lab.xml XBRL LABEL FILE Award Type [Axis] Warrants Option Related Party [Axis] Helidyne LLC [Member] Option Indexed to Issuer's Equity, Type [Axis] Employee Stock Option [Member] Hank Leibowitz Title of Individual [Axis] Chief Executive Officer [Member] Daniel Bogar Equity Components [Axis] Preferred Stock Common Stock Additional Paid-In Capital Accumulated Deficit Treasury Stock Document and Entity Information: Entity Registrant Name Document Type Document Period End Date Amendment Flag Entity Central Index Key Current Fiscal Year End Date Entity Common Stock, Shares Outstanding Entity Filer Category Entity Emerging Growth Company Entity Small Business Entity Current Reporting Status Entity Voluntary Filers Entity Well-known Seasoned Issuer Entity Shell Company Entity Interactive Data Current Entity File Number Entity Incorporation, State or Country Code Document Fiscal Year Focus Document Fiscal Period Focus Statement of Financial Position [Abstract] Assets Current Assets: Cash Accounts receivable Prepaid expenses and other current assets Total Current Assets Property and Equipment Property and equipment, net of accumulated depreciation of $107,641 and $107,007, respectively Other Assets License, net of accumulated amortization of $25,822 Total Other Assets Total Assets Liabilities and Stockholders' (Deficit) Equity Current Liabilities Accounts payable and accrued expenses Total Current Liabilities Long Term Liabilities Convertible note payable Total Long Term Liabilities Total Liabilities Stockholders' (Deficit) Equity Preferred Stock: 50,000,000 preferred shares authorized, 0 preferred shares issued at September 30, 2019 and December 31, 2018 Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 40,300,106 common shares issued and 31,750,106 common shares outstanding at September 30, 2019 and December 31, 2018 Additional paid-in capital Treasury stock, 8,550,000 shares at cost Accumulated deficit Total Stockholders (Deficit) Equity Total Liabilities and Stockholders' (Deficit) Equity Assets [Abstract] Property and equipment, net of accumulated depreciation License, net of accumulated amortization Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common Stock, par value Common Stock, shares authorized Common Stock, shares issued Common Stock, shares outstanding Treasury stock Revenues [Abstract] Revenue Operating Expenses Research and development General and administrative Total Operating Expenses Loss from Operations Other Income (Expenses) Interest income Loss on impairment Interest expense Total Other Income (Expense) Income (Loss) before Income Taxes Provision for Income Taxes Net Loss Net Income (Loss) per Share - Basic and Diluted Weighted Average Common Shares Outstanding - Basic and Diluted Statement [Table] Statement [Line Items] Balance Balance, Shares Stock based compensation Net loss Balance Balance, Shares Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows From Operating Activities Adjustments to reconcile net loss to net cash to net cash provided (used) by operating activities: Impairment of intangible assets Depreciation and amortization Amortization of debt issuance costs Changes in operating assets and liabilities: Accounts receivable and prepaid expenses Accounts payable and accrued expenses Liberty notes receivable Cash (Used) Provided by Operating Activities Cash Flows from Financing Activities Proceeds from notes payable, related party Payment for debt issuance costs Payment on notes payable, related party Cash provided by (used in) Financing Activities Net Change in Cash and Cash Equivalents Cash and cash equivalents at Beginning of Period Cash and cash equivalents at End of Period Supplemental Disclosure of Cash Flow Information Cash paid during the period for interest Financial Statements Condensed Consolidated Financial Statements Going Concern: Going Concern Policy Text Block [Abstract] Summary of Significant Accounting Policies Recent Accounting Prouncements Recent Accounting Pronouncements Business Combinations [Abstract] Intellectual Property and License Agreement Warrants Warrants Stock Options Stock Options Notes Payable to Related Parties Convertible Notes Payable to Related Parties Commitment and Contingencies: Commitments and Contingencies Related Party Transactions Related Party Transactions Subsequent Events [Abstract] Subsequent Events Nature of Business Cash Equivalents Accounts Receivables Revenue Recognition Property and Equipment Impairment of Long-Lived Assets Stock-based Compensation Common Stock Purchase Warrants Accounting for Uncertainty in Income Taxes Research and Development Costs Earnings (Loss) Per Share Financial instruments Use of Estimates Summary of warrants Stock Option Schedule of long-term debt Going Concern Details Narrative Working capital deficit Revenue percentage Impairment losses Antidilutive Excluded from Computation of Earnings Per Share, Amount Business Acquisition [Axis] Amortization expense Accumulated amortization of the intangible asset- intellectual property Commercial royalty obligation Annual royalty Impairment charge Balance at beginning Shares Issued Shares Expired Shares converted to Common Stock Options Balance at end Weighted Average Exercise Price Balance at beginning Weighted Average Exercise Price shares Issued Weighted Average Exercise Price shares Expired Weighted Average Exercise Price shares converted to Common Stock Options Weighted Average Exercise Price Balance at end Aggregate Intrinsic Value Balance at beginning Aggregate Intrinsic Value shares Issued Aggregate Intrinsic Value shares Expired Aggregate Intrinsic Value shares Converted to Common Stock Options Aggregate Intrinsic Value Balance at end Shares Begining Balance Granted Expired/forfeited Ending Balance Weighted Average Exercise Price Options Outstanding, Begining Balance, Weighted Average Exercise Price Granted Expired/forfeited Options Outstanding, Ending Balance, Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Options outstanding Begining Options outstanding Ending Share-based Payment Arrangement [Abstract] Stock-based compensation expense Unrecognized stock-based compensation Note payable to stockholders Less: Unamortized debt issuance costs Total long-term debt Royalty percentage Notes payable to stockholders Maturity date Interest rate Notes payable description Royalty percentage Company made payments Two monthly installments Committed to purchase price Revenue from product Option Purchased Exercise price Option expiration date Annual Salary Payments to related party Compensation Accrued compensation Custom Element. Custom Element. Custom Element. Custom Element. Commercial royalty obligation. Custom Element. Custom Element. Custom Element. Revenue from product. Assets, Current Other Assets [Default Label] Assets [Default Label] Liabilities, Current Liabilities, Noncurrent Liabilities Treasury Stock, Value Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses [Default Label] Operating Income (Loss) Goodwill, Impairment Loss Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Accounts Receivable and Other Operating Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Notes Receivables Net Cash Provided by (Used in) Operating Activities Payments of Debt Issuance Costs Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents, at Carrying Value WarrantTextBlock Share-based Payment Arrangement [Text Block] Related Party Transactions Disclosure [Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Long-term Debt Royalty percentage [Default Label] EX-101.PRE 14 pwvi-20190930_pre.xml XBRL PRESENTATION FILE XML 15 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Warrants (Tables)
9 Months Ended
Sep. 30, 2019
Warrants Abstract  
Summary of warrants

A summary of warrants issued, exercised and expired during the nine months ended September 30, 2019 is as follows:

 

   Shares  Weighted Average Exercise Price  Intrinsic Value
Balance at December 31, 2018   975,000   $.11     
Issued            
Expired            
Converted to Common Stock Options            
Balance at September 30, 2019   975,000   $.11     
XML 16 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2019
Commitment and Contingencies:  
Commitments and Contingencies

Note 9 - Commitments and Contingencies

 

On June 25, 2015, Company consultant Hank Leibowitz assigned to the Company a patent he obtained for a system and method for using high temperature sources in Rankine cycle power systems. The Company has agreed to pay Mr. Leibowitz a 2% royalty for any and all revenues of products and/or project sales by the Company based on the subject patent.

 

On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC to utilize the Helidyne intellectual property in order to use Helidyne expanders in Powerverde systems and to sell Helidyne expanders. As part of the licensing agreement the Company committed to purchase two 50 kW expanders, at a price of $25,000 each, on or before the sixth month anniversary of the agreement. The $50,000 was payable in two monthly installments of $25,000 beginning October 2016. The Company had made payments totaling $38,750, towards the purchase of the expanders, all of which was included in prepaid expense and other current assets in the consolidated balance sheets at December 31, 2016. Due to Helidyne’s failure to perform under the agreement, the Company has not made any further payments to Helidyne and does not intend to do so unless and until Helidyne performs as required. Helidyne has not objected to the Company’s position, and it is very unlikely that Helidyne will ever be able to perform.

 

The Company agreed to pay Helidyne LLC a royalty of 3% of sales, subject to a minimum annual royalty of $50,000 beginning on the earlier of commercialization of the product or three years from the effective date of the agreement. This minimum royalty would be payable only if Helidyne performs as required, which is very unlikely, or if the Company elects to produce its own expanders using Helidyne technology. The Company does intend to produce these expanders directly or through a contract manufacturer in the future. See Note 5.

 

On April 15, 2017, the Company entered into an assembly agreement with Liberty Plugins, Inc. (“Liberty”) to assemble Liberty’s Hydra electronic vehicle charging systems and ship completed Hydras to Liberty’s facility in Santa Barbara, California (the “Liberty Agreement”). Liberty has agreed to pay $1,000 for the first 10 Hydras assembled in a month, $750 per Hydra for the next 10 Hydras assembled per month and $500 per Hydra for each Hydra assembled above 20 per month. The Company has never assembled/shipped more than 10 Hydras in any month and does not expect to do so in the future. As of September 30, 2019, the Company has built and shipped 43 Hydras. Revenue for these products is reflected in the net revenue on the Company’s condensed consolidated statement of operations as follows: $9,000 and $14,000 for the nine months ended September 30, 2019 and 2018, respectively and $3,000 and $8,000 for the three months ended September 30, 2019 and 2018, respectively.

 

On September 1, 2019, the Company hired Daniel Bogar to serve as its President, reporting to the CEO. As compensation, Mr. Bogar received a fully-vested non-qualified option to purchase 1,000,000 shares of the Company’s common stock at an exercise price of $.10 per share, with an expiration date of June 30, 2026. In addition, Mr. Bogar will receive an annual salary of $90,000 beginning on the closing of a private financing with gross proceeds of at least $1,000,000; however, the Company will be permitted to defer the salary to the extent required to maintain solvency.

XML 17 R11.htm IDEA: XBRL DOCUMENT v3.19.3
Intellectual Property and License Agreement
9 Months Ended
Sep. 30, 2019
Business Combinations [Abstract]  
Intellectual Property and License Agreement

Note 5 – Intellectual Property and License Agreement

 

On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC for total consideration of $100,000 to utilize the Helidyne intellectual property in the manufacturing of planetary rotor expanders and the incorporation of same in the Company’s distributed electric power generation systems. The license agreement also grants the Company an exclusive license to sell the expanders whether manufactured by Helidyne or by the Company. The Company’s royalty obligation begins on the earlier of the commercialization of the product or three years from the effective date of the agreement. Once the royalty obligation begins, the minimum annual royalty is $50,000 for each of the first six years, and $100,000, per commercial year, for the remainder of the agreement. Helidyne has defaulted under the agreement. Royalties would be payable only if Helidyne performs as required, or if the Company elects to produce its own expanders using Helidyne technology. During the quarter ended June 30, 2019, management of the Company evaluated the continued default by Helidyne and determined that Helidyne will not be able to perform under the license agreement for the foreseeable future. The Company’s license agreement continues to be active and the Company may utilize the Helidyne intellectual property in marketing its own products. Under the terms of the license agreement, the Company has the right to develop a prototype utilizing the Helidyne technology at its own cost. Due to the continued default by Helidyne and the potential cost of developing its own prototype, the Company has determined that the intangible asset related to the above license agreement is impaired and recognized an impairment charge of $69,178 in the second quarter of 2019, which is 100% of the net carrying value. See Note 9.

 

For the nine months ended September 30, 2019 and 2018, amortization expense was $5,000 and $9,874, respectively and accumulated amortization of the intangible assets was $25,822 at December 31, 2018.

XML 18 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2019
Nov. 14, 2019
Document and Entity Information:    
Entity Registrant Name POWERVERDE, INC.  
Document Type 10-Q  
Document Period End Date Sep. 30, 2019  
Amendment Flag false  
Entity Central Index Key 0000933972  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   31,750,106
Entity Filer Category Non-accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Interactive Data Current Yes  
Entity File Number 000-27866  
Entity Incorporation, State or Country Code NV  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q3  
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Treasury Stock
Total
Balance at Dec. 31, 2017 $ 3,981 $ 12,129,331 $ (11,378,720) $ (491,139) $ 263,453
Stock based compensation 480,649 480,649
Net loss (603,944) (603,944)
Balance at Sep. 30, 2018 3,981 12,609,980 (11,982,664) (491,139) 140,158
Balance at Jun. 30, 2018 3,981 12,574,131 (11,871,738) (491,139) 215,235
Stock based compensation 35,849 35,849
Net loss (110,926) (110,926)
Balance at Sep. 30, 2018 3,981 12,609,980 (11,982,664) (491,139) 140,158
Balance at Dec. 31, 2018 3,981 12,609,980 (12,057,798) (491,139) 65,024
Stock based compensation 80,000 80,000
Net loss (426,814) (426,814)
Balance at Sep. 30, 2019 3,981 12,689,980 (12,484,612) (491,139) (281,790)
Balance at Jun. 30, 2019 3,981 12,609,980 (12,313,789) (491,139) (190,967)
Stock based compensation     80,000     80,000
Net loss (170,823) (170,823)
Balance at Sep. 30, 2019 $ 3,981 $ 12,689,980 $ (12,484,612) $ (491,139) $ (281,790)
XML 20 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 21 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2019
Policy Text Block [Abstract]  
Summary of Significant Accounting Policies

Note 3 – Summary of Significant Accounting Policies

 

Nature of Business

 

The Company is devoting substantially all of its present efforts to establish a new business involving the development and commercialization of clean energy electric power generation systems, and none of its planned principal operations have commenced. However, royalties from licenses unrelated to planned principal operations were recognized as revenue through March 2018, when the underlying license agreement terminated. No revenues from this planned principal operation have been generated.

 

Cash Equivalents

 

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.

 

Accounts Receivable

 

Accounts receivable consist of balances due from assembly services. The Company monitors accounts receivable and provides allowances when considered necessary. At September 30, 2019 and December 31, 2018, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.

 

Revenue Recognition

 

Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three and nine months ended September 30, 2019 and 2018.

 

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.

 

Impairment of Long-Lived Assets

 

Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses were recognized during the three and nine months ended September 30, 2018. For the nine months ended September 30, 2019, the Company recognized an impairment loss of $69,178.

 

Stock-based Compensation

 

The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

 

Common Stock Purchase Warrants

 

The Company accounts for common stock purchase warrants in accordance with ASC Topic 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASC 815-40”). Based on the provisions of ASC 815-40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company, or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of December 31, 2018 and September 30, 2019 were classified as equity.

 

Accounting for Uncertainty in Income Taxes

 

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. There is no uncertain tax positions as of September 30, 2019 and December 30, 2018.

 

Research and Development Costs

 

The Company’s research and development costs are expensed in the period in which they are incurred.

 

Earnings (Loss) Per Share

 

Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for 975,000 shares and options for 12,180,500 shares were excluded from weighted average common shares outstanding on a diluted basis.

 

Financial Instruments

 

The Company carries cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and notes payable, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

XML 22 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Share-based Payment Arrangement [Abstract]        
Stock-based compensation expense $ 80,000 $ 35,849 $ 80,000 $ 480,649
Unrecognized stock-based compensation $ 0   $ 0  
XML 23 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue percentage 100.00% 100.00% 100.00% 100.00%
Impairment losses     $ (69,178) $ 0
Warrants        
Antidilutive Excluded from Computation of Earnings Per Share, Amount     975,000  
Option        
Antidilutive Excluded from Computation of Earnings Per Share, Amount     12,180,500  
XML 24 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Going Concern
9 Months Ended
Sep. 30, 2019
Going Concern:  
Going Concern

Note 2 – Going Concern

 

We have financed our operations since inception through the sale of debt and equity securities and through Biotech IP licensing revenues which expired March 2018. As of September 30, 2019, we had a working capital deficit of $693 compared to a working capital deficit of $9,788 at December 31, 2018. This decrease in the working capital deficit is due primarily to cash raised through related party debt financing.

 

The Company has historically relied upon unrelated and related party debt and equity financing to fund its cash flow shortages and will require either additional debt or equity financing to sustain its operations. The Company’s revenues through 2018 were derived mainly from royalties under its Biotech licensing agreement, which expired in March 2018. Those factors create substantial doubt about the Company’s ability to continue as a going concern.

 

The Company continues to seek funding from private debt and equity investors, as it needs to promptly raise substantial additional capital in order to finance its plan of operations. There can be no assurance that the Company will be able to promptly raise the necessary funds on commercially acceptable terms, if at all. If the Company does not raise the necessary funds, it may be forced to cease operations.

XML 25 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenues [Abstract]        
Revenue $ 3,000 $ 8,000 $ 9,000 $ 173,094
Operating Expenses        
Research and development 114,620 71,415 184,301 596,128
General and administrative 49,938 47,511 159,326 181,832
Total Operating Expenses 164,558 118,926 343,627 777,960
Loss from Operations (161,558) (110,926) (334,627) (604,866)
Other Income (Expenses)        
Interest income 0 0 0 1,621
Loss on impairment 0 0 (69,178) 0
Interest expense (9,265) 0 (23,009) (699)
Total Other Income (Expense) (9,265) 0 (92,187) 922
Income (Loss) before Income Taxes (9,265) (110,926) (92,187) (603,944)
Provision for Income Taxes 0 0 0 0
Net Loss $ (170,823) $ (110,926) $ (426,814) $ (603,944)
Net Income (Loss) per Share - Basic and Diluted $ 0.01 $ 0.00 $ 0.01 $ 0.02
Weighted Average Common Shares Outstanding - Basic and Diluted 31,750,106 31,750,106 31,750,106 31,750,106
XML 26 R26.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options (Details)
9 Months Ended
Sep. 30, 2019
$ / shares
shares
Shares  
Granted
Expired/forfeited
Employee Stock Option [Member]  
Shares  
Begining Balance 11,180,500
Granted 1,000,000
Expired/forfeited
Ending Balance 12,180,500
Weighted Average Exercise Price  
Options Outstanding, Begining Balance, Weighted Average Exercise Price | $ / shares $ 0.20
Granted | $ / shares 0.10
Expired/forfeited | $ / shares
Options Outstanding, Ending Balance, Weighted Average Exercise Price | $ / shares $ 0.20
Weighted Average Remaining Contractual Life (Years)  
Options outstanding Begining 7 years 7 days
Options outstanding Ending 5 years 10 months 6 days
XML 27 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Going Concern (Details Narrative) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Going Concern Details Narrative    
Working capital deficit $ (693) $ (9,788)
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Convertible Notes Payable to Related Parties
9 Months Ended
Sep. 30, 2019
Notes Payable to Related Parties  
Convertible Notes Payable to Related Parties

Note 8 - Convertible Notes Payable to Related Parties

 

In the first quarter of 2019, the Company issued Convertible Promissory Notes totaling $290,000 to stockholders. The notes are to be paid in one principal payment, along with any unpaid interest by December 31, 2021. Interest is payable semiannually at 10%. The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021.

 

In May 2019, the Company issued a Convertible Promissory Note in the principal amount of $10,000 to a stockholder in connection with a loan in the same amount. Consequently, Convertible Promissory Notes have been issued in an aggregate principal amount of $300,000 during the first two quarters of 2019.

 

Long-term debt at September 30, 2019 consisted of the following:

 

   2019
    
Note payable to stockholders  $300,000 
Less: Unamortized debt issuance costs   18,903 
Total long-term debt  $281,097 

 

Amortization of the debt issuance costs is reported as interest expense in the income statement.

XML 29 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Recent Accounting Pronouncements
9 Months Ended
Sep. 30, 2019
Recent Accounting Prouncements  
Recent Accounting Pronouncements

Note 4 – Recent Accounting Pronouncements

 

In February 2016, the FASB issued ASU 2016-02, “Leases,” which created a new Topic, ASC Topic 842 and established the core principle that a lessee should recognize the assets, representing rights-of-use, and liabilities to make lease payments that arise from leases. For leases with a term of 12 months or less, a lessee is permitted to make an election under which such assets and liabilities would not be recognized, and lease expense would be recognized generally on a straight-line basis over the lease term. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018. The Company adopted ASC Topic 842 on January 1, 2019 and such adoption did not have any impact on the Company’s financial statements.

 

In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718).” ASU 2018-07 simplifies the accounting for nonemployee stock-based payment transactions. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018, and early application is permitted. The adoption of this guidance on January 1, 2019 did not have an impact on the Company’s financial statements.

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2019
Policy Text Block [Abstract]  
Nature of Business

Nature of Business

 

The Company is devoting substantially all of its present efforts to establish a new business involving the development and commercialization of clean energy electric power generation systems, and none of its planned principal operations have commenced. However, royalties from licenses unrelated to planned principal operations were recognized as revenue through March 2018, when the underlying license agreement terminated. No revenues from this planned principal operation have been generated.

Cash Equivalents

Cash Equivalents

 

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.

Accounts Receivables

Accounts Receivable

 

Accounts receivable consist of balances due from assembly services. The Company monitors accounts receivable and provides allowances when considered necessary. At September 30, 2019 and December 31, 2018, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.

Revenue Recognition

Revenue Recognition

 

Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three and nine months ended September 30, 2019 and 2018.

Property and Equipment

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses were recognized during the three and nine months ended September 30, 2018. For the nine months ended September 30, 2019, the Company recognized an impairment loss of $69,178.

Stock-based Compensation

Stock-based Compensation

 

The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

Common Stock Purchase Warrants

Common Stock Purchase Warrants

 

The Company accounts for common stock purchase warrants in accordance with ASC Topic 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASC 815-40”). Based on the provisions of ASC 815-40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company, or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of December 31, 2018 and September 30, 2019 were classified as equity.

Accounting for Uncertainty in Income Taxes

Accounting for Uncertainty in Income Taxes

 

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. There is no uncertain tax positions as of September 30, 2019 and December 30, 2018.

Research and Development Costs

Research and Development Costs

 

The Company’s research and development costs are expensed in the period in which they are incurred.

Earnings (Loss) Per Share

Earnings (Loss) Per Share

 

Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for 975,000 shares and options for 12,180,500 shares were excluded from weighted average common shares outstanding on a diluted basis.

Financial instruments

Financial Instruments

 

The Company carries cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and notes payable, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature.

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

XML 31 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 76 229 1 false 12 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://pwvi.com/20131231/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://pwvi.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://pwvi.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://pwvi.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Changes in Stockholders' Equity (Deficit) (Unaudited) Sheet http://pwvi.com/role/ChangesInStockholdersEquityDeficit Condensed Consolidated Changes in Stockholders' Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://pwvi.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Condensed Consolidated Financial Statements Sheet http://pwvi.com/role/FinancialStatements Condensed Consolidated Financial Statements Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Sheet http://pwvi.com/role/GoingConcern Going Concern Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://pwvi.com/20131231/role/idr_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Recent Accounting Pronouncements Sheet http://pwvi.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 10 false false R11.htm 00000011 - Disclosure - Intellectual Property and License Agreement Sheet http://pwvi.com/role/IntellectualProperty Intellectual Property and License Agreement Notes 11 false false R12.htm 00000012 - Disclosure - Warrants Sheet http://pwvi.com/role/Warrants Warrants Notes 12 false false R13.htm 00000013 - Disclosure - Stock Options Sheet http://pwvi.com/20131231/role/idr_DisclosureStockOptions Stock Options Notes 13 false false R14.htm 00000014 - Disclosure - Convertible Notes Payable to Related Parties Notes http://pwvi.com/role/ConvertibleNotesPayableToRelatedParties Convertible Notes Payable to Related Parties Notes 14 false false R15.htm 00000015 - Disclosure - Commitments and Contingencies Sheet http://pwvi.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 00000016 - Disclosure - Related Party Transactions Sheet http://pwvi.com/20131231/role/idr_DisclosureRelatedPartyTransactions Related Party Transactions Notes 16 false false R17.htm 00000017 - Disclosure - Subsequent Events Sheet http://pwvi.com/20131231/role/idr_DisclosureSubsequentEvents Subsequent Events Notes 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://pwvi.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://pwvi.com/20131231/role/idr_DisclosureSummaryOfSignificantAccountingPolicies 18 false false R19.htm 00000019 - Disclosure - Warrants (Tables) Sheet http://pwvi.com/role/WarrantsTables Warrants (Tables) Tables http://pwvi.com/role/Warrants 19 false false R20.htm 00000020 - Disclosure - Stock Options (Tables) Sheet http://pwvi.com/role/StockOptionsTables Stock Options (Tables) Tables http://pwvi.com/20131231/role/idr_DisclosureStockOptions 20 false false R21.htm 00000021 - Disclosure - Convertible Notes Payable to Related Parties (Tables) Notes http://pwvi.com/role/ConvertibleNotesPayableToRelatedPartiesTables Convertible Notes Payable to Related Parties (Tables) Tables http://pwvi.com/role/ConvertibleNotesPayableToRelatedParties 21 false false R22.htm 00000022 - Disclosure - Going Concern (Details Narrative) Sheet http://pwvi.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://pwvi.com/role/GoingConcern 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://pwvi.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details Narrative) Details http://pwvi.com/role/SummaryOfSignificantAccountingPoliciesPolicies 23 false false R24.htm 00000024 - Disclosure - Intellectual Property and License Agreement (Details Narrative) Sheet http://pwvi.com/role/IntellectualPropertyAndLicenseAgreementDetailsNarrative Intellectual Property and License Agreement (Details Narrative) Details http://pwvi.com/role/IntellectualProperty 24 false false R25.htm 00000025 - Disclosure - Warrants (Details) Sheet http://pwvi.com/role/WarrantsDetails Warrants (Details) Details http://pwvi.com/role/WarrantsTables 25 false false R26.htm 00000026 - Disclosure - Stock Options (Details) Sheet http://pwvi.com/role/StockOptionsStockOptionActivityDetails Stock Options (Details) Details http://pwvi.com/role/StockOptionsTables 26 false false R27.htm 00000027 - Disclosure - Stock Options (Details Narrative) Sheet http://pwvi.com/role/StockOptionsDetailsNarrative Stock Options (Details Narrative) Details http://pwvi.com/role/StockOptionsTables 27 false false R28.htm 00000028 - Disclosure - Convertible Notes Payable to Related Parties (Details) Notes http://pwvi.com/role/ConvertibleNotesPayableToRelatedPartiesDetails Convertible Notes Payable to Related Parties (Details) Details http://pwvi.com/role/ConvertibleNotesPayableToRelatedPartiesTables 28 false false R29.htm 00000029 - Disclosure - Convertible Notes Payable to Related Parties (Details Narrative) Notes http://pwvi.com/role/ConvertibleNotesPayableToRelatedPartiesDetailsNarrative Convertible Notes Payable to Related Parties (Details Narrative) Details http://pwvi.com/role/ConvertibleNotesPayableToRelatedPartiesTables 29 false false R30.htm 00000030 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://pwvi.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://pwvi.com/role/CommitmentsAndContingencies 30 false false R31.htm 00000031 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://pwvi.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://pwvi.com/20131231/role/idr_DisclosureRelatedPartyTransactions 31 false false All Reports Book All Reports pwvi-20190930.xml pwvi-20190930.xsd pwvi-20190930_cal.xml pwvi-20190930_def.xml pwvi-20190930_lab.xml pwvi-20190930_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true XML 32 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current Assets:    
Cash $ 32,104 $ 8,482
Accounts receivable 9,000 10,000
Prepaid expenses and other current assets 19,260 10,866
Total Current Assets 60,364 29,348
Property and Equipment    
Property and equipment, net of accumulated depreciation of $107,641 and $107,007, respectively 0 634
Other Assets    
License, net of accumulated amortization of $25,822 0 74,178
Total Other Assets 0 74,178
Total Assets 60,364 104,160
Current Liabilities    
Accounts payable and accrued expenses 61,057 39,136
Total Current Liabilities 61,057 39,136
Long Term Liabilities    
Convertible note payable 281,097 0
Total Long Term Liabilities 281,097 0
Total Liabilities 342,154 39,136
Stockholders' (Deficit) Equity    
Preferred Stock: 50,000,000 preferred shares authorized, 0 preferred shares issued at September 30, 2019 and December 31, 2018 0 0
Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 40,300,106 common shares issued and 31,750,106 common shares outstanding at September 30, 2019 and December 31, 2018 3,981 3,981
Additional paid-in capital 12,689,980 12,609,980
Treasury stock, 8,550,000 shares at cost (491,139) (491,139)
Accumulated deficit (12,484,612) (12,057,798)
Total Stockholders (Deficit) Equity (281,790) 65,024
Total Liabilities and Stockholders' (Deficit) Equity $ 60,364 $ 104,160
XML 33 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash Flows From Operating Activities    
Net loss $ (426,814) $ (603,944)
Adjustments to reconcile net loss to net cash to net cash provided (used) by operating activities:    
Impairment of intangible assets 69,178 0
Depreciation and amortization 5,633 16,783
Amortization of debt issuance costs 5,097 0
Stock based compensation 80,000 480,649
Changes in operating assets and liabilities:    
Accounts receivable and prepaid expenses (7,393) 350,359
Accounts payable and accrued expenses 21,921 (92,099)
Liberty notes receivable 0 34,000
Cash (Used) Provided by Operating Activities (252,378) 185,748
Cash Flows from Financing Activities    
Proceeds from notes payable, related party 300,000 0
Payment for debt issuance costs (24,000) 0
Payment on notes payable, related party 0 (150,000)
Cash provided by (used in) Financing Activities 276,000 (150,000)
Net Change in Cash and Cash Equivalents 23,622 35,748
Cash and cash equivalents at Beginning of Period 8,482 1,336
Cash and cash equivalents at End of Period 32,104 37,084
Supplemental Disclosure of Cash Flow Information    
Cash paid during the period for interest $ 10,747 $ 699
XML 34 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Convertible Notes Payable to Related Parties (Details) - USD ($)
Sep. 30, 2019
Jun. 30, 2019
May 31, 2019
Mar. 31, 2019
Notes Payable to Related Parties        
Note payable to stockholders $ 300,000 $ 300,000 $ 10,000 $ 290,000
Less: Unamortized debt issuance costs 18,903      
Total long-term debt $ 281,097      
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Intellectual Property and License Agreement (Details Narrative) - USD ($)
9 Months Ended
Jun. 01, 2016
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Amortization expense   $ 5,000 $ 9,874  
Accumulated amortization of the intangible asset- intellectual property       $ 25,822
Impairment charge   $ 69,178 $ 0  
Helidyne LLC [Member]        
Commercial royalty obligation $ 100,000      
Annual royalty $ 50,000      
XML 36 R20.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options (Tables)
9 Months Ended
Sep. 30, 2019
Stock Options  
Stock Option

Stock option activity for the nine months ended September 30, 2019, is summarized as follows:

 

     Shares  Weighted Average Exercise Price  Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2018    11,180,500   $0.20    7.02 
Granted    1,000,000    0.10     
Expired/forfeited              
Options outstanding at September 30, 2019    12,180,500   $0.20    5.85 
XML 37 R31.htm IDEA: XBRL DOCUMENT v3.19.3
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Payments to related party $ 11,420 $ 10,050 $ 30,334 $ 28,380
Hank Leibowitz        
Compensation     67,500  
Accrued compensation     $ 30,000  
XML 38 R16.htm IDEA: XBRL DOCUMENT v3.19.3
Related Party Transactions
9 Months Ended
Sep. 30, 2019
Related Party Transactions  
Related Party Transactions

Note 10 - Related Party Transactions

 

Since July 2010, the accounting firm J.L. Hofmann & Associates, P.A. (“JLHPA”), whose principal is our CFO John L. Hofmann, has provided financial consulting and accounting services to the Company. In December 2017, J.L. Hofmann & Associates, P.A. merged with Kabat, Schertzer, De La Torre, Taraboulos & Co, LLC (“KSDT”). The Company paid $30,334 and $28,380 for its services in the nine months ended September 30, 2019 and 2018, respectively and $11,420 and $10,050 in the three months ended September 30, 2019 and 2018, respectively.

 

The Company’s consultant and shareholder Hank Leibowitz receives compensation of $7,500 per month, totaling $67,500 for the first nine months of 2019. At September 30, 2019, Mr. Leibowitz was owed accrued compensation of $30,000.

XML 39 R12.htm IDEA: XBRL DOCUMENT v3.19.3
Warrants
9 Months Ended
Sep. 30, 2019
Warrants Abstract  
Warrants

Note 6 – Warrants

 

A summary of warrants issued, exercised and expired during the nine months ended September 30, 2019 is as follows:

 

   Shares  Weighted Average Exercise Price  Intrinsic Value
Balance at December 31, 2018   975,000   $.11     
Issued            
Expired            
Converted to Common Stock Options            
Balance at September 30, 2019   975,000   $.11     
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments and Contingencies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 01, 2019
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Oct. 01, 2016
Jun. 01, 2016
Jun. 25, 2015
Royalty percentage               2.00%
Company made payments       $ 38,750        
Two monthly installments           $ 25,000    
Revenue from product   $ 3,000 $ 8,000 $ 9,000 $ 14,000      
Helidyne LLC [Member]                
Royalty percentage             3.00%  
Annual royalty             $ 50,000  
Two monthly installments             50,000  
Committed to purchase price             $ 25,000  
Daniel Bogar | Chief Executive Officer [Member]                
Option Purchased 1,000,000              
Exercise price $ .10              
Option expiration date Jun. 30, 2026              
Annual Salary $ 90,000              
ZIP 42 0001575705-19-000119-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001575705-19-000119-xbrl.zip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end XML 43 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Subsequent Events
9 Months Ended
Sep. 30, 2019
Subsequent Events [Abstract]  
Subsequent Events

Note 11 – Subsequent Events

 

The Company’s management evaluated subsequent events through November 14, 2019, in connection with the preparation of these condensed consolidated financial statements, which is the date these financial statements were available to be issued. There are no subsequent events to report as of this date.

XML 44 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options
9 Months Ended
Sep. 30, 2019
Stock Options  
Stock Options

Note 7 – Stock Options

 

Stock option activity for the nine months ended September 30, 2019, is summarized as follows:

 

     Shares  Weighted Average Exercise Price  Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2018    11,180,500   $0.20    7.02 
Granted    1,000,000    0.10     
Expired/forfeited              
Options outstanding at September 30, 2019    12,180,500   $0.20    5.85 

 

Total stock option compensation for the nine months ended September 30, 2019 and 2018 was $80,000 and $480,649, respectively. All of the 2019 options were granted to the Company’s president, who was hired in September 2019. See Note 9. There is no unrecognized compensation expense associated with the options.

XML 45 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 46 R3.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Assets    
Property and equipment, net of accumulated depreciation $ 107,641 $ 107,007
License, net of accumulated amortization $ 25,822 $ 25,822
Preferred stock, shares authorized 50,000,000 50,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common Stock, par value $ 0.0001 $ 0.0001
Common Stock, shares authorized 200,000,000 200,000,000
Common Stock, shares issued 40,300,106 40,300,106
Common Stock, shares outstanding 31,750,106 31,750,106
Treasury stock 8,550,000 8,550,000
XML 47 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Financial Statements
9 Months Ended
Sep. 30, 2019
Financial Statements  
Condensed Consolidated Financial Statements

Note 1 – Condensed Consolidated Financial Statements

 

The accompanying unaudited condensed consolidated financial statements prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report of PowerVerde, Inc. (“PowerVerde,” “we,” “us,” “our,” or the “Company”) as of and for the year ended December 31, 2018. The results of operations for the three and nine months ended September 30, 2019, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of PowerVerde, Inc., formerly known as Vyrex Corporation (the “Company”), and PowerVerde Systems, Inc., formerly known as PowerVerde, Inc., its wholly-owned subsidiary. Intercompany balances and transactions have been eliminated in consolidation.

XML 48 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Warrants (Details)
9 Months Ended
Sep. 30, 2019
USD ($)
$ / shares
shares
Warrants Abstract  
Balance at beginning | shares 975,000
Shares Issued | shares
Shares Expired | shares
Shares converted to Common Stock Options | shares
Balance at end | shares 975,000
Weighted Average Exercise Price Balance at beginning $ 0.11
Weighted Average Exercise Price shares Issued
Weighted Average Exercise Price shares Expired
Weighted Average Exercise Price shares converted to Common Stock Options
Weighted Average Exercise Price Balance at end 0.11
Aggregate Intrinsic Value Balance at beginning
Aggregate Intrinsic Value shares Issued
Aggregate Intrinsic Value shares Expired
Aggregate Intrinsic Value shares Converted to Common Stock Options | $
Aggregate Intrinsic Value Balance at end
XML 49 R21.htm IDEA: XBRL DOCUMENT v3.19.3
Convertible Notes Payable to Related Parties (Tables)
9 Months Ended
Sep. 30, 2019
Notes Payable to Related Parties  
Schedule of long-term debt

Long-term debt at September 30, 2019 consisted of the following:

 

   2019
    
Note payable to stockholders  $300,000 
Less: Unamortized debt issuance costs   18,903 
Total long-term debt  $281,097 
XML 50 R29.htm IDEA: XBRL DOCUMENT v3.19.3
Convertible Notes Payable to Related Parties (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
May 31, 2019
Royalty percentage        
Notes payable to stockholders $ 290,000 $ 300,000 $ 300,000 $ 10,000
Maturity date Dec. 31, 2021      
Interest rate     10.00%  
Notes payable description The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021.      
EXCEL 51 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end